Obesity Research · Vol. 7, No. 1 · 2020 · pp. 19–45 · e-ISSN 2377-8385

The Association of Dietary Fatty Acids and Gut Microbiota Alterations in the Development of Neuropsychiatric Diseases: A Systematic Review

Kulvinder Kochar Kaur, Gautam Allahbadia, Mandeep Singh

Scientific Director, Centre for Human Reproduction 721, Jalandhar 144001 , Punjab, IndiaIndia
Scientific Director, Ex-Rotunda-Centre for Human Reproduction, Bandra (W), Mumbai 400040, Maharashtra, IndiaIndia
Consultant Neurologist, Swami Satyanand Hospital, Near Nawi Kachehri, Baradri, Ladowali road, Jalandhar, Punjab, IndiaIndia

DOI: https://doi.org/10.17140/oroj-7-143 · Published 2020-09-30 · Licence: https://creativecommons.org/licenses/by/4.0 · © 2020 The Author(s)

Abstract

Aim Having reviewed earlier the role of probiotics in obesity and other associated metabolic disorders like non-alcoholic fatty liver disease (NAFLD), engineering probiotics for cholera and other neuronal diseases like Alzheimer’s, Parkinson disease with incidence of obesity and diabetes mellitus (DM) so much on the rise, Here the aim of this systematic review is to highlight the influence of dietary patterns, like fatty acids, other lipids on role of maternal stress and the neuropsychiatric disease (NPD) formation along with influence of probiotics in reverting them. Method A systematic review was carried out using the PubMed, Web of Science, Medline, Embase, Cochrane reviews, and Google Scholar, Search engine with the MeSH Terms; “Impaired lipid metabolism”; “Oxidative stress”; “inflammation”; “Gut Microbiota (GM)”; “NPD”; “Schizophrenia (SCZ)”; “Autism Spectrum Disorder (ASD)”; “Bipolar disorders (BD)”; “Gamma amino butyric acid (GABA)”; “5-hydroxy tryptamine (5HT)”; “Brain derived neutrotrophicfactor (BDNF)”; “Polyunsaturated fatty acids (PUFA)”; “Saturated (SFA)”; “Depression”; “Resolvins”; “Protectins”; “Short chain fatty acids (SCFA)”; “Probiotics”; “Fecal Transplantation” from 1990 till June 2020. Results We found a total of 900 articles under various subheadings of GM and NPD and probiotics with NPD and SCZ, ASD. One hundred ninety-two (192) articles got selected for this comprehensive review. No meta-analysis was conducted. Conclusion We observed a marked correlation among dietary habits, like utilization of Western diet (WD) with marked escalation of intake of high fat, high sugar rich diet escalated n6 PUFAS over n3 PUFAS and influence on GM that is not helpful in digestion of the nondigestible fibers in form of starch along with generation of butyrate aiding in certain beneficial effects and on formation of various neurochemicals like escalation of BDNF while increased GABA, reduced 5HT formation alteration of tryptophan metabolism is seen in these WD food and we have tried to detail the role of SCFA formation, generation of resolvins and how they work in the formation of various NPD besides maternal diet during pregnancy and how it determines infants microglial priming and later determinants of early stress.

Keywords: Dietary fat; Western diet; Microbiota to brain communication (MBC); Polyunsaturated fatty acids (PUFA); Gut microbiota (GM); Schizophrenia (SCF); Autism spectrum disorder (ASD)

Method

A systematic review was carried out using the PubMed, Web of Science, Medline, Embase, Cochrane reviews, and Google Scholar,

Search engine with the MeSH Terms; “Impaired lipid metabolism”; “Oxidative stress”; “inflammation”; “Gut Microbiota (GM)”;

“NPD”; “Schizophrenia (SCZ)”; “Autism Spectrum Disorder (ASD)”; “Bipolar disorders (BD)”; “Gamma amino butyric acid

(GABA)”; “5-hydroxy tryptamine (5HT)”; “Brain derived neutrotrophicfactor (BDNF)”; “Polyunsaturated fatty acids (PUFA)”;

“Saturated (SFA)”; “Depression”; “Resolvins”; “Protectins”; “Short chain fatty acids (SCFA)”; “Probiotics”; “Fecal Transplanta-

tion” from 1990 till June 2020.

Results

We found a total of 900 articles under various subheadings of GM and NPD and probiotics with NPD and SCZ, ASD. One hun-

dred ninety-two (192) articles got selected for this comprehensive review. No meta-analysis was conducted.

Conclusion

We observed a marked correlation among dietary habits, like utilization of Western diet (WD) with marked escalation of intake of

high fat, high sugar rich diet escalated n6 PUFAS over n3 PUFAS

digestible fibers in form of starch along with generation of butyrate aiding in certain beneficial effects and on formation of various

neurochemicals like escalation of BDNF while increased GABA,

seen in these WD food and we have tried to detail the role of SCFA formation, generation of resolvins and how they work in the

formation of various NPD besides maternal diet during pregnancy and how it determines infants microglial priming and later de-

terminants of early stress.

Keywords

Dietary fat; Western diet; Microbiota to brain communication (MBC); Polyunsaturated fatty acids (PUFA); Gut microbiota (GM);

Schizophrenia (SCF); Autism spectrum disorder (ASD).

cc Copyright 2020 by Kaur KK. This is an open-access article distributed under

allows to copy, redistribute, remix, transform, and reproduce in any medium or format, even commercially, provided the original work is properly cited. and influence on GM that is not helpful in digestion of the non-

reduced 5HT formation alteration of tryptophan metabolism is

Creative Commons Attribution 4.0 International License (CC BY 4.0), which

Introduction

t has been realized that what our dietary habits are, in addition

to what diet comprises of besides the way it is consumed has a

I strong influence on brain health. Over the past few years exten-

sive work has been conducted to understand the critical signifi-

cance of trillions of bacteria that are present in the gastrointestinal

tract (GIT) along with dynamic interaction among the heterog-

enous make-up of this large microorganism community along with

chances of getting various diseases like obesity, type 2 diabetes

mellitus (T2DM), pain, neurodevelopmental, neurodegenerative

as well as neuropsychiatric diseases.1 An ecosystem comprised of

trillions of commensals in the form of bacteria, archaea, protozoa

as well as viruses whose collective microbiome is known as micro-

biota.2 Further we have reviewed in various studies, it has signifi-

cance that bidirectional gut-brain dialogue occurs via a complicated

communication network that is inclusive of the sympathetic as

well as parasympathetic branches of the autonomic nervous sys-

tem (ANS), the hypothalamo-pituitary-adrenal axis (HPA) axis of

the endocrine system, the immune system as well as the enteric

nervous system (ENS). Parallel to this the liberation of enteroen-

docrine hormones can remarkably modulate host physiology. Ac-

tually, enteroendocrine hormones cells liberate various hormones

like glucagon like peptide 1 (GLP1), peptide-YY (PYY), cholecys-

tokinin (CCK), as well as serotonin (5HT), with a crucial influence

on nutrient absorption, metabolism as well as appetite, as well as

further manipulate anxiety–like behaviors. Hence gut-brain axis

has a part in integrating hormonal, immune as well as neural sig-

nals in a communication system by which the gut microbiota (GM)

community as well as its metabolites as well as permeability, muco-

sal immune function,6 along with influence brain neurochemistry

and processing of emotional as well as rewarding behaviors.3,7 In

this complex system, bacterial metabolites like short chain fatty

acids (SCFAS) (like butyrate or butyric acid (BA), acetate (AC) as

well as propionate or propionic acid (PPA), immune mediators

(chemokines), signals as well as bidirectional crosstalk through the

vagus nerve represent the main routes that bring about microbio-

ta to brain communication (MBC). For further corroboration of

crucial part of vagus pathway, both harmful actions through lipo-

polysaccharide (LPS) delivery or advantage of probiotics supple-

menting get suppressed or blunted through inactivation of vagal

6,8 communication.6,8 Afferents from vagus nerve to brain impact the

hypothalamo- pituitary adrenal (HPA) axis action along with co-

ordinated responses to physical as well as emotional stressors, as

well as liberation of hypothalamic corticotrophin releasing factor

(CRF) as well as adrenocorticotropic hormone (ACTH) liberation

via pituitary gland.9 After having reviewed the GM in obesity as

well as non-alcoholic fatty liver disease (NAFLD), metabolic dis-

orders, proteins and GM, probiotics in obesity as well as NAFLD,

10-14 engineering probiotics.

i) We concentrated on association among microbiota as well as

brain disorders.

ii) Emphasis was laid on correlation among dietary lipids, chang-

es in microbiota-brain communication (MBC), as well as vulner-

ability to NPDs like schizophrenia (SCZ), depression as well as

autistic spectrum disorders (ASD).

iii) Influence of selected dietary lipids, whether they had a pro-

tective or preventive potential against pathogenesis of neuro-

psychiatric disease (NPD). Of fatty acids (FA’s) especially sig-

nificance of poly-unsaturated fatty acids (PUFA), their role in

chronic inflammation situation as well as function of pro resolv-

ing mediators in protecting from NPD was attempted.

iv) Western diet (WD)-global nutrition with significance of WD

in inducing chronic inflammatory situations affecting intestinal

as well as brain physiology was elaborated.

v) Diet composition as well as gut bacteria metabolites, along

with their ability to synthesize short chain fatty acids (SCFA) as

well as contribution of SCFA absence contributed to the devel-

opment of psychiatric illnesses is reviewed.15

Method

A systematic review was carried out using the PubMed, Web of Sci-

ence, Medline, Embase, Cochrane Reviews, Google Scholar Search

engine with the MeSH Terms; “Impaired lipid metabolism”; “Oxi-

dative stress”; “Inflammation”; “Gut Microbiota (GM)”; “NPD”;

“Schizophrenia (SCZ)”; “Autistic spectrum disorders (ASD)”;

“Bipolar disorders (BD)”; “Gamma amino butyric acid (GABA)”;

“5-hydroxy tryptamine (5HT)”; “Brain derived neutrotrophicfac-

tor (BDNF) polyunsaturated fattyacids (PUFA)”; “Saturatedfatty-

acids (SFA)”; “Depression”; “Resolvins”; “Protectins”; “Short

4 chain fatty acids (SCFA)”; “Probiotics”; “Fecal Transplantation”

5 from 1990 till June 2020 was conducted.

Results

We found a total of 900 articles under various subheadings of GM

and NPD and probiotics with NPD and SCZ, ASD. One hundred 3,7

ninety-two (192) articles got selected for this comprehensive re-

view. No meta-analysis was conducted.

Neuropsychiatric Diseases as well as Microbiota

The changes in microbiota ecosystem might negatively influence

brain physiology has been pointed with an escalated chance of

psychiatric illness.16 Further the correlation among microbiota

change as well as brain disease gets suggested by the comorbidity

among psychiatric disorder as well as variety of gastrointestinal

(GI) diseases like irritable bowel syndrome (IBS) as well as enter-

opathies along with the effectiveness of probiotics (i.e psychobi-

otics) on stress stimulated GI symptoms, as well as anxiety along

17,18 with depression. Further unanticipated is the illustration of the

pathophysiology of GI disorders or systemic inflammation can get

spread among organisms via transfer of the GM among patients or

pathological animal models to germ free mice.19 Influence of GI

diseases on mental health,17 gets corroborated by the huge utiliza-

tion of antidepressants in the population of IBS patients, that

convincingly support the part of emotional stress in dysbiosis, gut

motility as well as epithelial integrity . It is actually well understood

that prenatal, early postnatal, as well as adulthood stress have a

key part in the pathogenesis of various psychiatric illnesses.21 Mi-

crobiome can directly influence stress response, as well as germ

free (GF) mice having absence of commensal GM show a hyper

response towards stress, as well as exaggerated HPA activation that

has the property of overexpression of CRF gene as well as protein,

escalation of plasma ACTH as well as corticosterone, as well as

decreased expression of hippocampal brain derived neurotrophic

factor (BDNF).22 Significantly these actions can dramatically be

ameliorated via colonization of juvenile (but not adult) mice with

the separate strain Bifidobacterium infants or accelerated by the

correlation of enteropathogenic Escherichia Coli.22 Maladaptive re-

sponses in terms of reduced, anxiety-like behaviours have been

detailed in GF mice along with the normalization of dysfunctional

risk taking behaviours after colonizing at early formation. As-

tonishingly brain formation gets dramatically influenced by the

microbiome, actually morphological changes of neural dendrites

have been found in the hippocampus as well as amygdala of GF

mice.23 This supports the posit that GM control brain formation in

adult mature neurons too, besides in adult hippocampal neurogen-

esis has been detailed to be greater in GF as compared to conven-

tional mice irrespective of postweaning microbial colonization.24

If removal of commensal GM escalates, the chances of

maladaptive behaviours that can get fully reversed only within mat-

urational time, the potent effect of GM on neuron plasticity as well

as circuitry wiring at the time of neurodevelopment might escalate

the tendency towards stress –stimulated psychiatric disorders. Any-

way during formation25 as well as adulthood, probiotics administra-

tion might abrogate social stress stimulated cognitive, behavioural

Figure 1. The Figure Depicts the Main Impact of Different Sources of Environmental Burden on the Derangement of Gut Microbiota Ecosystem, and a Selection of Potential Mechanisms Underlying Dysbiosis-Induced Liability to Neuropsychiatric Diseases (NPDs). Here (left side), are depicted two recognized key pathogenetic factors such as: 1-(upper figure) the worldwide consumption of western diet characterized for instance by high saturated fat and high-sucrose foods, corn-derived fructose and carbonated beverages; 2-(lower side) multiple prenatal stress, maternal immune activation and early-life stressors. Chronic exposure to either one or both sources of environmental burden can determine systemic and brain inflammation and alteration of brain homeostasis via intestinal microbiota dysbiosis and severe immune changes such as shifting towards a persistent activation of the microglial phenotype, production of inflammatory cytokines, ROS and decrease of BDNF and 5-HT synthesis. In turn,

the combination of neuronal, microglial and astrocyte damage (e.g., atrophy and reduced neurogenesis), altered synaptic and neural communication and brain inflammation contribute to

the risk of depression, SCZ and ASD.

18,26 (anxiety, depressions) as well as immune changes. For this a

significant study is the one where stress stimulated hyperthermia,

enhancement of corticosterone amounts, anxiety as well as de-

pressions like behaviours, got decreased following chronic therapy

6,23 with Lactobacillus rhamnosus (JB1) probiotic.6,23 The anti-depressant

as well as anxiolytic actions of L. rhamnosus (JB1) therapy got me-

diated via selective escalation of GABA (B) receptors mRNA ex-

pression in the cingulate cortex as well as reduction of GABA (B)

expression in hippocampus as well as amygdala as well as enhance-

1,23 6 ment of GABA (A) expression in hippocampus. All these altera-

tions caused by L. rhamnosus (JB1) therapy in GABA brain expres-

sion got repressed following vagotomy in mice along with notable

decrease in the anti-depressant as well as anxiolytic actions.6 Hence

brain neurochemical alterations implicating the GABAergic system

get illustrated following probiotics administration in various animal

models, as well as significance of vagus nerve integrity for keeping

MBC intact as well as probiotic-correlated neurochemicals action.

Actually the bidirectional GM-brain crosstalk involves neuroendo-

crine as well as neuroimmune signalling modes,27 as crucial routes

of communication via HPA axis along with vagus nerve. Regard-

ing association of the utilization of probiotics as anti-depressant

therapy, there is proof that rats undergoing chronic unpredictable

mild stress for stimulating depression like behaviours had an esca-

lated amount of Firmicutes which had positive association with

colonic 5HT metabolism as well as negative one with 5HT in the

prefrontal cortex (PFC), both changes of 5HT metabolism got re-

versed via treatment with L.rhamnosus and Bifidobacterium longum.28

Role of GM in depressions is the changes of GM diversity, that

is seen in depressed patients, along with the probability of using

fecal transplantation for transferring the microbial “signature’’ of

microbiota depleted animals and stimulate a depression like phe-

notype.29 Further the depression like phenotype seen in GF mice

can get accelerated via the transplantation, of depressed micro-

biota from patients with major depressive disorder in microbiota

depleted mice.30 From this angle minocycline-stimulated changes

in microbiota composition can ameliorate the depression like be-

haviours exaggerated in mice via the exposure to chronic restraint

stress.31 Significantly, this study illustrated that chronic stress de-

creased Bifidobacterium species which inhibits the inflammation

correlated with nuclear factor kappa B (NFκB) pathway whereas at

same time enhanced the Lactobacillus species that are implicated

in inflassome activation through IL-1β liberation.31 A 16S rRNA

gene evaluation along with a wide metagenomic sequencing study

recently conducted on a large cohort of depressed patients has as-

sociated various microbial taxa (i.e enterotypes) with quality of life

(QOL) of participants as well as incidence of depression.32 Like

results demonstrated that decreased microbial density of Bacte-

roides correlates with <chances of depression as well as decreased

indicators of QOL.32 Knowing that gamma amino butyric acid

(GABA) as well as dopamine (DA) are neuroactive products of

microbial metabolism,18 this study further found the DA metabo-

lite 3, 4-dihydroxy phenyl acetic acid (DOPAC) as “gut-brain mod-

ule” positively associated with mental QOL, whereas a tendency

towards the correlation among escalated GABA synthesis as well

as depression was also observed (Figure 1).

Manipulation

Impaired Microbial Ecosystem Neuroinflammaton, as well as Chances of NPD’s

Influence of impaired MBC in the etiopathogenesis of NPD’s can

be evaluated in the form of systemic as well as brain inflammation

along with the risk for the defense of the homeostasis of the brain.

In this framework, it is of marked significance that the function

of surveillance conducted by microglial cells via very dynamic as

well as plastic morphological alterations. The microglial phenotype

might switch (from ‘’surveying’’ to ‘’activated’’) as per the changes

of neural activity, neuronal-microglial signals as well as synaptic

34,35 communication (Figure 1). Microglial cells representing the

main resident as well as immunocompetent cells of the brain get

activated by tissue damage, infection as well as in the course of

neuropsychiatric as well as neurodegenerative diseases.36

Significantly, a recent proof that maternal microbiota

can influence the development as well as function of microglial

offspring, that finally, is based on the integrity of the maternal

gut-brain interaction.35 Various risk factors in Autism spectrum

disorders (ASD) as well as schizophrenia (SCZ) pathogenesis,

like generalized maternal immune activation as well as early–life

stress, can stimulate besides neuroinflammation aberrant microg- 36-38 lial activation too. Further alteration of host immunity also oc-

28 39 curs besides stability of resident bacterial community.39 Proof for

neuroinflammation-correlated microglial activation in SCZ as well

as ASD patients has also been corroborated by positron emission

tomography (PET) studies, where an enhanced expression of the

translocator protein (TSPO) (a marker of microglial activation) oc-

curred.40 Thus, unhealthy dietary patterns can get classified as the

intake of saturated fats, wich a direct connection to low-grade sys-

temic inflammation, obesity as well as proinflammatory immune

response (Figure 1).41 Further recent proof is that microglial acti-

vated neuroinflammatory signalling has a causal association among

excessive intake of high fat diet (HFD) along with hypothalamic

gliosis, hence acting as a crucial player in HFD induced brain in-

42-44 flammation as well as deranged energy homeostasis. In case

unhealthy dietary patterns can powerfully decide the changes of

host microbial community as well as dysbiosis produces microbial

31 34 hyperactivity (Figure 1 ),34 then the input of selected dietary lipids

might markedly aid in regulating microglial activation, brain inflam-

mation as well as finally decreasing the chances of NPD’s (Table

1).

Dietary Lipids-Fatty Acids, Changes in Microbiata Diversity, as well as NPD’s

Normally fatty acids (FA’s) might be classified as per the num-

ber of double bonds in the side chain, from saturated fatty acids

(SFA’s) that lack the double bond, to mono-unsaturated fatty acids

(MUFA), with a single-double bond along with poly-unsaturated

fatty acids (PUFA), displaying 2 or greater double bonds in the

32 45,46 carbon chain. As FA’s can further get classified as per the car-

bon chain length along with the position of the first double bond

on the methyl terminal, then the full family of PUFAs can further

get categorized by including the omega-3 PUFAs (n-3 PUFAs) as

well as the omega 6 PUFAs (n-6 PUFAs) series. Both n-3 PUFAs

as well as n-6 PUFAs are essential nutrients in view of absence of

particular enzymes (i.e desaturases) they can’t get manufactured de

novo in mammals.47 Due to this intake through dietary sources of

the two 18 carbon (18C) essential fatty acids, linoleic acid (18:2n-6,

LA) along with α linolenic acid (18:3n-3, ALA) is required to form

the biologically active n-6 PUFAs as well as n-3 PUFAs, respec-

tively. As per the chain length ,the best known n-3 PUFAs form the

shorter chain precursor to the n-3 series ALA, the stearidonic acid

(SDA, 18:4), the long chain (≥C20) eicosapentaenoic acid (EPA,

20:5) along with docosahexaenoic acid (DHA, 22:6). Besides the

family of n-6 PUFAs include the shorter chain precursor to the n-6

series LA, the arachidonic acid (ARA, 20:4), the gamma-linolenic

acid (GLA, 18:3) as well as the dihomo-γ-linolenic acid (DGLA,

20:3).

Lot of proof has emphasized on the pro as well as anti

inflammatory potential given through the 2 series n-6 as well as n-3

PUFAs, respectively. Knowing the harmful influence of WD on

microbial ecosystem, the escalated intake of n-6 PUFAs enriched

vegetable oils (like soybean, corn sunflower as well as margarines)

along with red meat in the form of major sources of LA along with

ARA, is the biggest factor causing the huge enhancement of n-6:

n-3 ratio. Significantly the pro-inflammatory chronic response

Table 1. GM, Microglial Activation, Neuro inflammation and NPD’s/Brain Alterations

Ref.

Author/s GM Neuroinflammation Microglial Activation NPD/NDD Misc.

No

+nt-Basic idea of study Infl signatures at 198,5

see alteration of GM weeks adulthood and

Thion et al dsignatures in both adult Ear;ier GM defined Activation in womb unhealthy Basic motive

and fetuses in male 7 own signatures but

female near delivery maternasl

36 Only shown NDD assoc By tissue damage, infection Heneka MT Occurs in inf ,TD with microglia changes and in NPD,NDD

Change basic idea of Aberrant Influence brain

study to see how brain Stimulated by dev esp microglia that Bilbo 37 dev early life affected by aberrant MiA, Early life liberate cytokines &infl

environmental factors stress factors =>proneness to

change like virus inf NPD like ASD

Change again basic idea 38 possible epigenetic Bergdolt et al is how MIA influences Aberrant MA model

NPD

Changed gut has 1013 Can influence HPA axis

To 1014 org dev

39 10 times >cells and 150 GF mice raised show inc Dinan et al permeability times >genes act host stress

genome Even E.Coli Monocolonisation with

enters Bifidobacterium

NC only idea of study

40 was to see influence of Suzuki et al Augmented MA But not altered MA in ASD SCZ and ASD Abn microglial activation

on ASD dev

Valdearcos et al 42 Changed Present Abnormal HFD Hypothalamic gliosis Obesity

promoted via n-6 PUFAs is correlated to ARA-produced signal-

ling pathway, synthesizing bioactive lipids known as eicosanoids as

well as isoprostanes,50 that get influenced in atherogenic processes,

aberrant cell proliferation (like cancer), obesity, as well as irritable

bowel disease (IBD). The eicosanoids family are prostaglandins

(PGs), prostacyclins, thromboxanes (TXs), lipoxins (LXs) as well

as leukotrienes (LTs), having various parts in cytokine production

along with amplifying or decreasing inflammation.52 In contrast,

n-3 PUFAs regulate inflammation by the precursor ALA mainly

and then through EPA along with DHA synthesis. Actually EPA as

well as DHA act as competitive substrates for n-6 PUFAs metabo-

lism along with ALA-synthesized pro-inflammatory eicosanoids.

Noticeably, a recent metabolomic study on a cohort of SCZ pa-

tients illustrated aberrantly enhanced serum amounts of SFA,

MUFA as well as n-6 PUFSs as a probable sequence of greater

than normal desaturation from SFAs to MUFAs and hence insuf-

ficient brain energy supply.53

Presently attention has been laid on the mode of in-

flammation resolution with n-3 PUFAs obtained lipids called

“specialized pro-resolving mediators’’ (SPM’s) which consists of

various members of significant molecules like lipoxins, resolvins,

Dietary

Lipids

Inc female both in fetus

and adiult showed > Dec chance of NPDs

Decided right in womb

and microglial activation Proper dietary

lipid given Of study

More in female both in

GM Influenced thewir early and adult life

dev

Abberant

Microglial dev with

changes predispose

To ASD and SCZ dev in

late life

Abberant Aberrant MA

Further stress can ASD

cause inc gut Imp to nstudy GM

Alteration

Lot of GM changes In dev of IBS and

seen in Depression

IBS and ASD hence normalizes

PET Study -AUGMENTED PET—incr

TSPO-MA-marker Compared to controls

protectins as well as maresins.54 Deficiency of n-3 PUFAs have

been constantly documented in SCZ patients, bipolar disorders as

well as depression as well as no proof that EPA along with DHA

supplementation might be advantageous in a subgroup of ASD

55,56 patients. In a longitudinal 7-years study recently, the escalation

of n-6:n-3 ratio at baseline as found in a cohort of young persons

with “ultra high-risk’’ for depression was observed to be true as

well as correct anticipator of chances of forming later mood dis-

orders.57

Collecting studies have evaluated the association among

diet supplementation with n-3 PUFAs as well as NPDs, the in-

fluence on microbiota, symptoms of severity of patients with

major depressive disorders, SCZ or ASD patients is still not well

understood. By utilizing transgenic mice that have the capacity to

oversynthesize n-6 PUFAs as well as enhance the n-6:n-3 ratio it

has been feasible to show the formation of various pathogenic

cascades that involve, metabolic endotoxaemia, fatty liver as well as

cancers, besides other metabolic syndrome components.58 Further

besides exhibiting chronic inflammation (like serum LPS, intestinal

permeability as well as tumor necrosis factor alpha (TNFα), inter-

leukin 1 beta (IL-1β) as well as IL-6 overexpression) but also the

evaluation of faecal samples showed higher amounts of Enterobac-

teriaceae bacteria, with enhanced proteobacteria with decreased bac-

teroides as well as a Actinobacteria phylum (Figure 2).57 Many, markers

of gut dysbiosis along with intestinal permeability in faecal samples

like greater amounts of 1-methyl nicotinamide, cysteine, histidine

and spermidine agree with the probable causal association among

enhanced n-6 PUFAs tissue content, abnormal alteration in gut

microbiota (GM) as well as disease formation.57 Same outcomes

were documented in mice fed with high n-6 PUFAs diet.58 In the

same study it was found that the liberation of intestinal alkaline

phosphatase (IAP) the major mode by which the transgenic eleva-

tion of n-3 PUFAs tissue amount can give an anti inflammatory

potential, stimulate the growth of bifidobacterium, decreased LPS

amount, gut permeability as well as metabolic endotoxaemia.58

Conversely, indirect positive actions of n-3 PUFAs di-

etary supplementation on the chances of forming chronic de-

pressive symptoms have been recently detailed.59 A randomized,

double-blind as well as stratified study of the effect of family vio-

lence on child behaviour documented that n-3 PUFAs nutritional

intervention in children decreased the amount of psychological

aggression in adult caregivers.59 n-3 PUFAs enriched diet exposure

during pregnancy can develop a particular maternal n-3 PUFAs

environment which in turn can “prime’’ offspring microbial com-

position in early life and give protection at adulthood. Actually, en-

dogenous synthesis of n-3 PUFAs in the pregnancy time has been

demonstrated to shape offspring GM as well as develop progeny

against HFD-stimulated metabolic changes.60 Though little num-

ber of studies have evaluated the correlation among n-3 PUFAs

supplementation, manipulation of MBC as well as early-life stress,

there is proof that longtime EPA as well as DHA supplementation

can restore the GM composition in maternally separated rats.61

Based on this, significant implication for n-3 PUFAs supplementa-

tion are there for avoidance of stress induced chances of mood

disorders. As per a meta-analysis of the biological status of n-3

PUFAs in mood disorders, plasma as well as brain EPA as well

as DHA amounts were found to be decreased in depression pa-

tients.62 Significantly, inspite of inverse correlation among dietary

fish intake as well as incidence of depression, as well as the posi-

tive correlation among eicosanoids synthesis, depression as well as

SCZ,63 the causative assocciation among n-3 PUFAs supplementa-

tion, Firmicutes: Bacteroides ratio as well as antidepressants action

is still not clear. Like in case of depression EPA as well as DHA

amounts are observed to be reduced in ASD children.64 Further,

in a placebo controlled study, plasma BDNF amounts were esca-

lated by EPA as well as DHA diet supplementation in 1st episode

psychotic patients were observed to have inverse correlation with

depressive symptoms.65 n-3 PUFAs deprived diet feeding to rats

demonstrated decreased amounts of brain derived neutrotrophic

factor (BDNF) expression within prefrontal cortex (PFC), an area

considered to be of key significance in the pathophysiology of

depression, SCZ as well as ASD.66

The probable mode of association among n-3 PUFAs

reservoir deficiency as well as chances of NPDs might be further

found in the neuroinflammatory pathways as well as neuroimmune

changes correlated with depression or SCZ pathogenesis. Inter-

estingly, a strong anti-inflammatory as well as protection action through macrophage stimulation as well as inhibition of NLRP3

inflammasome activation as well as IL-1β liberation was shown in

57 67 mice fed with n-3 PUFAs enriched diet.67 Being key parts of the

innate immune response there is the activation of toll-like recep-

tors (TLRs), that represent a family of transmembrane proteins,

mostly expressed, besides on the immune cells (like macrophages)

but further on cells of the intestinal epithelium (like enterocytes)

where receptors get associated with avoidance of systemic low

grade inflammation as well as GM colonization, like through sens-

ing of polysaccharide A on Bacteroides fragilis.68 TLRs recall the

pathogen-associated molecular patterns (PAMPs) for avoidance of

progression of inflammation as well as gut microbiota (GM) colo-

nization. Regulation of immunological responses, TLRs can inhibit

the activation of proinflammatory cytokines or NFκB-modulated

inflammatory programme as well as preservation of intestinal ho-

meostasis by decreasing the entry of bacterial products to cyto-

69 70 solic inflammasome.69 TLRs as emphasized70 represent necessary

parts of gut immune system having the ability to control intestinal

homeostasis, hence having a crucial part for resilience or suscep-

tibility to particular situations where GM dysbiosis is common

like IBD. In the same study, it was also shown that impairment

of TLRs action correlates with metabolic derangement (like DM)

besides with various brain pathologies like neuroinflammation that

are typical of neurodegenerative diseases.70

LPS-forming gram–negative bacteria activate the TLR4

subtype,70 stimulating the formation of various proinflammatory

markers (like TNFα, IL-1β as well as IL-6) along with a cascade

of pathogenetic inflammatory processes. From this angle, the dis-

turbance of microbial community, as documented in SCZ patients

regarding astroglial as well as microglial activation, impairment of

neurogenesis as well as alterations in glutamate transmissions as

well as NMDA receptor subunits.71 Hence dietary alterations along

with modulation of GM diversity might interfere with sensitivity

of TLRs activation as well as form a state of lot of neuroimmune

changes, enhancing the chances of neuro developmental disor-

ders like SCZ as well as ASD. Intake of dietary fats can either

escalate or ameliorate LPS amounts as well as TLR4-correlated in-

flammatory signalling, based on the kind of dietary fats. Actually

SFAs like lauric along with palmitic acid can activate TLRs-mod-

ulated inflammatory program.72 That a significant crosstalk does

take place among the common intake of a carbohydrate-based/

PUFA-enriched diet has been demonstrated to be correlated with

< fasting LPS plasma amounts as well as chance of endotoxae-

mia.73 The influence of LPS plasma amounts gets more clear by

st knowing these outcomes in the presence of earlier study, where

intake of Mediterranean–like diet (like MUFA enriched) reduces

the post-prandial (PP) proinflammatory response > than intake of

PUFA-enriched diet as well as much > SFA-based diet.74 Actually

mixture of n-3 PUFAs/n-6 PUFAs composition might exaggerate

the proinflammatory potential just above the amount of MUFA

based diet, but in anyway < that given by SFA high-diet. Various

evaluations have played the significance of reciprocal controlling

role caused by SFAs as well as n-3 PUFAs on the activation of

TLR4 as well as TLR2 subtype.75 Besides SFAs activation, whereas

n-3 PUFAs as well as especially DHA, deactivate TLR4 as well

as TLR2 correlated inflammatory processes, SFA’s can stimulate

dimerization of TLR4 as well as TLR2 followed by translocation

of these receptors into lipid raft of the plasma membrane hence

promoting the down stream signalling that is conversely inhibited

via DHA.72

Without any doubt the close connection, that involves di-

etary fats, endotoxaemia, changes in microbiome as well as NPDs

makes it complicated to get the insight of the chain processes. Still

the unhealthy influence caused via HFD diet on proteins expres-

sion/distribution of the enterocyte tight junctions corroborates

the point that consumption of certain diet fats is the primary stim-

ulus causing intestinal permeability as well as > susceptibility to

NPDs. A significant factor correlating diet fats to intestinal barrier

function as well as intestinal permeability is the susceptibility of

diet lipids to escalate bile acid liberation as well as associated bile

acid modulated signalling, toxicity as well as changes of enterocyte

tight junction proteins.77 The deleterious actions of SFAs on the

integrity of intestinal barrier overtake that caused by the intake

n-6 PUFAs-enriched HFD. Actually, animals given SFAs enriched

high fat diet (HFD) show reduced barrier integrity as well as infil-

tration of inflammatory immune cells (like neutrophils), that are

not found in n-6 PUFAs-enriched HFD or n-3 PUFAs-enriched

HFD.78 As per this diet n-3 PUFAs have been demonstrated to

ameliorate experimental colitis,79 as well as EPA given protection

against inflammation-stimulated dysfunction of permeability of

intestinal epithelial barrier (“leaky gut”).80

Pro Resolving Lipid Mediators, Intestinal Inflammation and NPD’s

Both pro or anti-inflammatory bioactive lipid metabolites

are synthesized through the enzymatic oxidation brought about via

cyclooxygenases (COXs), lipoxygeneses (LOXs) and cytochrome

P450 (CYP450) monooxygenases. Especially from the AA the

COX pathway yields PG’s as well as TX’s, whereas the LOX as well

as LOX produces LTs as well as LXs. Conversely, diet n-3 PUFAs

can form enough EPA along with DHA plasma as well as brain

amounts ,that are LOX as well as CYP substrates, that get steadily

correlated with a strong anti-inflammatory action opposing both

the expression of cytokines like TNFα, IL-1β as well inflammatory

stimuli like LPS.

Considering this n-3 PUFAs represent bioactive lipid

modulators to facilitate the inflammation resolving through the

generation of EPA as well as DHA-produced “specialized pro-

resolving members’’ (SPMs). Such EPA as well as DHA produced

lipid metabolites represent anti inflammatory as well as represent

the pro-resolving members’ of the oxylipin family, that are re-

solvins (RVs), protectins (PDs) as well as maresins (MaR).83 These

resolving series are the main EPA as well as DHA produced SPMs

as well as especially, resolvinE (RvE) as well as resolvinD (RvD)

series once produced via EPA as well as DHA respectively. In-

spite of absence of a direct proof that RvE as well as RvD have

an influence on GM, lot of evidence is there that the n-3 PU-

FAs confer antimicrobial effect as well as that situations where

low grade chronic inflammation as well as epithelial damage (like

IBD, ulcerative colitis as well as CD) get totally or partially resolved

via resolvins-modulated amelioration of intestinal inflammation.

Further the DHA produced RvD1 as well as RvD2 work via the binding to selected G-protein coupled receptors (GPCR’s), like

GPR32 (DRV1) as well as GPR18 (DRV2), respectively, whereas

EPA generated RvE via capacity to binding to Chemokine–like re-

ceptor 1, Chem R23 (ERV1).86 Significantly exogenous delivery of

high amount of RvD1 besides aiding in transepithelial resistance

in SFA-enriched HFD fed mice,78 hence relieving gut inflamma-

tion, besides removing dihydrogen sulphide (H2S) yielding bacteria

as well as especially SFA-correlated escalated Desulfovibrio species.

75,76 Regarding NPDs 2 studies gave proof of antidepressant action via

intracerebroventricular (ICV) infusion of RvD1 as well as RvD2,87

or EPA generated RvE 3,88 in a mouse model of LPS-stimulated

antidepressant-like behaviour. In concordance, antidepressant -like

action was also detailed after ICV infusion of RvE1/RvE2 in PFC

or hippocampus, probably through Chem R23 binding.89 Thus role

of n-3 PUFAs on intake or nutritional administration, EPA as well

as DHA produced RVs, PDs as well as MaR provide an integrated

effect having lots of immunomodulatory actions changing GM

population, intestinal epithelial integrity, removal of intestinal in-

flammation as well as resident immune cells responding. Inspite of

lot of proof supporting that diet n-3 PUFAs intake can either avoid

or abrogate both NPD as well as gut dysbiosis part of EPA as well

as DHA produced RVs, PDs as well as MaR in the form of micro-

biome as well as immune system manipulation is not clear. Actually

good research has detailed the composite depressive phenotype,

the escalated Firmicutes to Bacteroides ratio as well as the LPS re-

sponsiveness stimulated via n-3 PUFAs deficit nutritionally in case

of gestational female as well as male offsprings,90 or the avoidance

actions stimulated by diet n-3 PUFAs acting on depressive–like

behaviours as well as alterations of GM composition stimulated

via social imbalance at the time of brain formation.91 However,

getting insight in the association among dietary lipids, changes in

microbial ecosystem as well as chances of NPDs formation would

require evaluation of RVs, PDs as well as MaR correlated signalling

81 watching the part of the inflammation program that are the inhibi-

tion of proinflammatory modulators, the avoidance of neutrophil

recruitment/infiltration, monocyte stimulation, control of poly-

morphonuclear neutrophils (PMN) apoptosis, clearaing of bacilli,

macrophage phagocytosis getting induced as well as facilitate the

54,83 chemokine scavenging.

HT-Dopamine as well as NPDs n-3 PUFAs

Knowledge has accumulated that n-3 PUFAs-generated RVs, PDs

as well as MaR have an influence in neuroprotection, whereas n-6

PUFAs-produced eicosanoids (like PG’s, prostacyclins, TXs, LxS

as well as LTs) have significance in the pathogenesis of NPDs like

83 92 SCZ.92 The presence of aberrations of Phospholipid turnover in

SCZ is of significance. Initially, it appears that COX2 inhibitor ce-

lecoxib confers advantageous actions in SCZ patients,93 as well as

84 that eicosanoids might elevate DAergic neurotransmission as well

as have influence besides on SCZ, as well as in refractory depres-

94,95 sion along with ASD. In this aspect, the common consumption

of n-6 PUFAs- as well as the very large amounts of ARA present

in WD has the capacity to aberrantly escalate the amounts of PG’,

TXs, LxS as well as upregulate systemic as well as brain expres-

85 sion of proinflammatory enzymesa (like phospholipase A2, COX2

as well as genes (like TNF-α, IL-1β). WD stimulated subnormal

n-6: n-3 ratio enhance dysbiosis of GM stimulating impairment in

the capacity of immune system to act against inflammation as well

as sustain intestinal homeostasis. The inverse association among

reduced peripheral as well as brain DHA amounts as well as se-

verity of SCZ symptomatology,96 corroborates the probability of

diet n-3 PUFAs in mode of SCZ neuropathology.97 Once there is

preclinical n-3 PUFAs deficit of brain DHA amounts, it was dem-

onstrated that it changes DA function that can be similar to that

illustrated in SCZ patients.98 In a similar way, in a preclinical form

of amphetamine-stimulated SCZ like behaviour, diet n-3 PUFAs

administration decreased behaviour deficiencies, cytokine release

as well as elevated the action of combined antipsychotic as well as

celecoxib drug therapy.99 As brain deficit of DHA amounts might

change the expression of DA receptors in ventral striatum as well

as aid in hypofunctioning of, mesolimbic DA system as well as

15,100,101 anhedonia as seen in depression, the prenatal or early pre-

natal deficiency of n-3 PUFAs in the brain might be a key factor

in pathogenesis of depression. Neurotransmitters significant for

NPDs like dopamine (DA) as well as serotonin have a part in see-

ing to it that microbial community is preserved that is necessary for

the bidirectional MBC33 as well as both DA as well as monoamines

are believed to be critical actors in the pathogenesis of SCZ as well

as depression.102 Significantly, there is proof that various kinds of

dietary fatty acids might have separate actions on serotonin neuro-

transmission.103 Actually 5HT2A as well as 5HT2C receptor bind-

ing was decreased in the mamillary nucleus (in the interface of

the hypothalamic area) of rats with the use of a SCFAs-rich diet,

whereas the intake of a n-6 PUFAs- rich diet decreased 5HT2A as

well as receptor binding in the mamillary nucleus, 5HT2C receptor

binding in the prefrontal cortex (PFC) as well as 5HT2 transport-

ers (5HTT). This study further emphasized on the significant

belief that the main actions of brain serotonin function (recep-

tor binding as well as transporters got stimulated via the intake

of n-6 PUFAs-rich diet with significant influence on NPDs. Re-

garding DA, it further gets supported via the large amounts of

tyrosine hydroxylase observed in small intestine. Further more,

antibiotics-stimulated GM removal reduces intestinal generation in

mice,105 as well as GF mice displayed unequal brain mRNA expres-

sion of DA D1 receptor (D1R), getting in the hippocampus as well

as decreased in dorsal as well as ventral striatum level.1 Thus DA

metabolism gets dramatically altered via the changes of GM com-

munity. An imbalance among DA as well as its metabolites like ho-

movanillic acid (HVA) as well as DOPAC have been detailed in GF

rats as well as mice along with decrease in DA as well as serotonin

106,107 turnover. Significantly a reduction of HVA/DA ratio point-

ing to a decreased DA turnover was seen in GF rats,107 along with

cerebrospinal fluid (CSF) of patients with major depressive epi-

sode.108 Further antibiotics-stimulated dysbiosis enhance amounts

of l3,4–dihydroxy phenylalanine (L-DOPA) in PFC as well as hip-

pocampus with both L-DOPA as well as HVA in the amygdale,109

giving extra observation that brain DA amount, turnover as well as

metabolism are associated with the changes of GM composition.

The clinical utilization of atypical antipsychotic (AAP) amounts

bring about remission but further change fecal GM composition

in SCZ patients,110 hence showing that AAP’s therapy correlates

with particular alterations in intestinal bacilli population that might

reason out the various clinical effectiveness along with the severe

AAP’s correlation with impaired adverse actions.111 Metabolic im-

pairment in offspring as well as susceptibility for metabolic diseases (obesity, T2D) gets modelled at the pregnancy time with

a crucial input of the close crosstalk among n-3 PUFAs as well

as dietary lipids as well as GM environment. While maternal n-3

PUFAs scenario including pregnancy as well as lactation time, can

markedly refashion the offspring GM in mice and give long-term

protection to the progeny, the decrease of dietary n-3 PUFAs can

remove the amount of species needed for gut homeostasis like Ak-

kermansia muciniphilia.60 Hence, in a mouse model of pregnancy

depriving of dietary lipids demonstrated harmful influence on the

112,113 GM synthesis of SCFAs. Though deficiency of SCFAs cor-

relate mainly with chances of IBD as well as metabolic diseases,114

there is escalating proof that microbial, metabolism-produced SC-

FAs are critical actors in NPD pathogenesis. Knowing the harmful

influence of n-3 PUFAs dietary deficiency on striato nigral as well

as mesocorticolimbic DAergic neurons as well as BDNF expres-

sion,115 along with the key part of DA neurotransmission in the

NPD pathogenesis,102 especially focus has to be kept on the future

on dietary lipids correlated modes influencing the gut synthesis of

catecholamines as well as manipulation of ENS (Table 2).

Gut Microbiota (GM) Community as well as SCFAs-NPD’s

Influence

In reference to particular dietary nutrients as influencing the

changes in GM community as well as chances of NPD’s, one has

to pay attention on a special class of lipids generated from micro-

bial metabolism as well as comprising of SCFAs. Nutrients han-

dling via GM metabolism forms a complicated signalling system

mainly made up of SCFAs, L-tryptophan (Trp) as well as metabo-

33,116 lites along with neuroactive agents. Trp metabolism as well as

neuroactive agents are of critical signals to get insight of the as-

sociation among MBC as well as chance of NPD’s. GM generate

a neurochemical signal intrinsically like DA, γ amino butyric acid

(GABA), 5HT, acetyl choline (Ach), histamine, melatonin as well

104 27,117 as noradrenaline, that are critical elements for getting insight

into the mode of MBC influencing the impaired behaviours like

depression, anxiety as well as ASD. As precursors of peripheral as

well as brain generated serotonin, the amino acid (Trp) gets con-

verted via tryptophan hydroxylase (TPH) enzyme to 5HTP to 5HT

.118 by the aromatic L-amino acid decarboxylase.118 Thus Trp metabo-

lism is needed for central serotonin generation as well as serotonin

neurotransmission in both CNS, as well as in the ENS of the wall

of the gut.119 Hence as a result dietary induced alterations of mi-

crobial metabolism might possess an etiological influence in the

NPD pathogenesis via changes in SCFAs, Trp metabolism as well

as neuroactive agents. In this main concentration is on the associa-

tion among unhealthy diet, impairment of SCFAs generation of as

well as probable mode of depression, ASD as well as SCZ.

Microbial Community Impairment with- WD

Best study showing the robust influence of dietary habits on GM

composition, associates with the impact various diets generate

on host physiology. The marked influence of dietary habits on mi-

crobial community is possibly associated to the effects of various

diets generating in host physiology. With the worldwide adaptation

of WD, maximum population of developed as well as developing

countries has shifted their diet lifestyles to exaggerated intake of

high fat, high sucrose, as well as ultraprocessed food items.Without

any doubt WD is responsible for the etiopathogenesis of obesity,

colorectal cancer as well as chronic inflammatory situations influ-

encing the intestines like in Crohn’s disease (CD), as well as Ul-

cerative colitis that is part of the IBDs.120 Highly rich in saturated

fats, refined grains, corn generated fructose, proteins via the highly

processed red meats, salt, alcohol, sweetened as well as carbonated

beverages,121 as well as its intake correlates with dysbiosis as well

as impaired microbial community (Figure 1). Thus WD intake

alters the symbiotic association with dysbiosis as well as altered

microbial ecosystem along with gut mucosa influencing host me-

tabolism has been seen to be implicated in the intake of redmeat as

well as coronary heart disease through dietary phosphatidyl choline

along with synthesis of the proatherosclerotic metabolite trimethyl

amine-N-oxide. With lots of proof against WD as well as dys-

biosis, WD is also the cause of escalated intestinal permeability as

well as endotoxaemia, as proved in CD.124 Commensals in the GIT

that belong to Fermicutes phylum having proven immunomodula-

tory as well as anti-inflammatory actions, Faecali bacterium prasnitzii

(F.prausnitzi) get decreased in patients with CD, whereas its supple-

mentation as a probiotic is thought to be a treatment method for

CD.125 Biggest problem related to WD intake is the reduction in

both microbial community thought to be protective bacteria with

the expansion of pro-inflammatory as well as invasive Proteobac-

teria (like E.Coli) with dramatical decrease in SCFAs.126 The escala-

tion of pathogens as well as mucin breaking bacteria like the Mol-

licutes class of the Firmutes phyla, that includes Clostridia group

as well as Proteobacteria, is believed to be behind the decrease of

Bacteroides phyla, hence decrease the Microbial ecosystem.127 As

decrease in SCFAs-generating bacteria is crucial for dysbiosis, gut

mucosal inflammation as well as loss of intestinal barrier integrity,

it becomes significant to know dietary patterns manipulate the gen-

eration of the main gut bacteria metabolites.

Role of SCFAs-Dietary composition and Gut Bacteria

Metabolites

In the absence of gut bacteria it would become impossible to de-

grade nondigestible. Dietary nutrients, particularly plant derived

dietary fibres. These complicated carbohydrates are made up of

the resistant starch, oligosaccharides as well as non starch polysac-

charides that are utilized by gut bacteria in the form of energy

substrates for forming via fermentation, SCFAs, especially acetate

(C2), Propionate (C-3), Butyrate (C-4) as well as lactate.116 Intake

of fermentable, nondigestible carbohydrates give a lot of advanta-

geous actions, varying from reduced chances of colorectal cancer

114,128 as well a s amelioration of T2DM. Though advantages of SC-

FAs have been shown by various modes (like histone deacetylase

(HDAC) inhibition), SCFAs need to be thought to be immuno-

regulatory metabolites, especially the regulatory T-cells (Treg),129 as

well as crucial actors in the crosstalk among gut as well as immune

system. That way SCFAs aid in immunosurveillance by their bond-

ing to the metabolite-sensing GPCR like GPR41, GPR43 as well as

GPR109A, that are abundantly expressed on immune cells. Like

Butyrate can work as immune messenger by its ability to stimulate

T-cells to form IL-10 via GPR109A activation, hence repressing

carcinogenesis by producing antiinflammatory actions (like colon 130 nd inflammation). This 2 messenger action of SCFAs also involve

the control of gene expression, improving glucose metabolism,

cholesterol formation along with gut liberation of hormones like

PYY as well as GLP1.131 Fermentation of nondigestible carbohy-

drates as well as SCFAs synthesis also regulates brain function,

knowing that butyrate can cause neuroprotective action as well as

improve cognitive function,132 along with propionate decrease ac-

tivation of brain areas) like caudate and nucleus accumbens), that

are implicated in reward processing in healthy people asked to look

122 133 at pictures of palatable food items. Emphasizing is the effect

caused by certain bacterial species as well as their association with

dietary patterns is the part played in immune homeostasis along

with gut health by F. Prausnitzii. It has capacity to colonize human

intestine that relates to the intake of dietary fibres,134 as well as

the expansion of F. Prausnitzii is also of crucial significance for its

ability to generate butyrate, whose involvement in various neuro-

logical as well as psychiatric disorders is always getting examined.

Depression as well as SCFAs

Lot of evaluation of microbial dysbiosis as well as change in

bacterial composition in cases having depression has shown the

presence of a major switch towards enhancing of bacteroides as

well as a proteobacteria phyla as well as less than in healthy cases

proportion of the Firmutes phyla that includes Lachinospiraceae as

well as Ruminococcaceae, that has a crucial part in SCFAs synthe-

sis.136 Once Fecalibacterium is present it demonstrates a tendency

on decrease the severity of depression like symptoms along with

excessive amounts of Enterobacteriaceae escalates in depressed

patients. Butyrate generation is the most significant connection

among diet, SCFAs as well as psychiatric disorders. Actually in-

spite of its organic make-up, butyrate has the capacity of inhibiting

strongly classes I as well as IIa HDAC action,137 as well as inhibi-

tion of histone acetylation has been demonstrated to counteract

depression–like behaviour in preclinical animal models.138 These

observations concentrate on the alterations of gene transcription

via the changes of chromatin structure through modifications as

well as DNA methylation have shown that epigenetic modes as

well as chromatin remodelling can give promising other methods

to usual antidepressive therapy like selective serotonin reuptake in-

hibitors (SSRIs), serotonin noradrenaline reuptake inhibitors (SN-

RIs), tricyclic antidepressants (TCA), or MAO inhibitors.139 Mainly

the evaluation of chromatin remodelling has aided in unravelling

the modes via which environment (diet, stress as well as drugs of

abuse) can generate alterations in gene expression. Hence histone

acetylation gets facilitated via histone acetyl transferases (HATs) as

well as correlated with enhanced access to transcription machinery

as well as gene expression, while decreased transcription as well as

gene repression get stimulated through absence of histone acety-

lation as well as HDAC-stimulated escalation of ionic crosstalk

among histones as well as DNA, markedly condensed chromatin as

well as densely packing of DNA.140 Significantly, valproic acid (VA),

that is a mood stabilizer having neuroprotective as well as antide-

pressant potential,141 along with SCFAs as well as HDAC inhibitory

129 137 action. By prevention of withdrawl of acetyl groups through his-

tone proteins, the HDAC inhibitors prevent histone acetylation,

hence activation of gene transcription. HDAC inhibitors appear

to extend onto same neurotrophic factors thought to be respon-

sible for neuroplasticity as well as depressive disorder along with

HDAC downregulation has been correlated to the effectiveness of

antidepressant therapy (like imipramine) in the social defeat stress

model of depression.142 Especially antidepressant therapy can pre-

vent social defeat–stimulated BDNF downregulation within the

hippocampus as well as PFC,143 as well as HDAC inhibitors like

VA as well as sodium butyrate can upregulate BDNF expression

along with protect midbrain dopaminergic neurons.144 Following

oral delivery, butyrate can cross blood brain barrier (BBB), as well

as work in the brain in the form of HDAC inhibitors, and shown

via escalation of neuronal histone acetylation along with induction

of neurogenesis.145 Both antidepressant-like action as well as en-

hancement of hippocampal histone H4 acetylation has been seen

following continuous delivery of sodium 6 butyrate, as well as

normalizing hippocampal BDNF expression, histone H3 acetyla-

tion, along with reduce chronic restraint stress stimulated depres-

sive behavior.147 Significantly, besides demonstrating antidepres-

sant potential butyrate delivery also liberated F. prausnitzii species

that, has demonstrated to cause equivalent antidepressant actions

against chronic unpredictable stress (CUS)-stimulated depression

–like behaviour in rats. Further F. prausnitzii delivery restored

an anti-inflammatory environment via enhancement of plasma

amounts of interleukin-10 (IL-10) as well as avoiding the enhanced

stress-stimulated liberation of pro-inflammatory C-reactive protein

along with IL-6.148 Additionally to the well-known association

among antidepressant treatment as well as BDNF expression in

hippocampus along with prefrontal cortex (PFC) of depressed pa-

tients,149 MAO deficit is thought to be the major explanatory posit

of depression pathophysiology as well as subsequently SSRI,SNRI

as well as MAO inhibitors being the main treatment agents. A re-

Table 2. Role of 5-HT- Dopamine and n3PUFA in NPD’s

Ref. ProResolving Mediators Author/s n-3 /6PUFA No (PRM)

92 n3 generated, Skosnik et al Eicosanoids (PG’s,prostacyclins, SCZ n-6 generated

93 Phospholipid turnover Zheng et al

94 And eicosanoids might inc Grosso et al n3 generated

Tamiji et al 95 Same-lipid metabolism Same

96 Inverse relation of dec Hoen et al

Suggested Montenos-Rueda 97 n3PUFAinvolvement – et al deficient in RBC’s

Chalon 98 n3PUFA deficiency Dec of DHA content

99 n3PUFA dietary El Sayed et al supplementation

n3PUFA

Sublette et al status imp in prenatal/ Brain deficiency

early postnatal deficits

Camardes et al ciprocal association appears to be present among serotonin trans-

mission as well as BDNF expression, by which BDNF aids in se-

rotonin neuronal differentiation, formation as well as function, as

well as potentiation of serotonin signalling (like SSRI50 delivery)

propagates neural as well as astrocytes BDNF expression.150 The

antidepressant action of butyrate delivery appears to have the same

control among BDNF expression as well as serotonin neurotrans-

mission mutually. Thus various HDAC inhibitors with butyrate fa-

cilitates cell differentiation through the potentiation of serotonin-

stimulated BDNF gene expression,151 as well as butyrate delivery

was demonstrated to counteract CUS-stimulated anhedonic symp-

toms through the escalation of serotonin brain amounts along

with reversal of serotonin amounts along with reversal of CUS

146 152 -stimulated BDNF expression. That SCFAs have a role in neu-

roplasticity, neurogenesis, consolidation of long-term memory as

145,153 well as the sustainance of BBB integrity, gives further corrob-

oration to the fact that butyrate as well as SCFAs liberating bacteria

might be advantageous dietary formed neuroprotective as well as

antidepressant compounds. Significantly, besides butyrate, propio-

nate also has a protective effect over microbial infections as well as

oxidative stress (OS) stimulated escalation of BBB permeability.

Actually, the capacity of SCFAs to give protective effect against

impaired MBC as well as deranged BBB integrity is very significant

for preserving the main defensive structure of the brain as well as

act against NPD pathogenesis. Lastly ,the alteration of bacterial

community as well as escalation of valeric acid synthesis has been

detailed in positive association with depressive symptoms,155 SC-

FAs which can influence neurotransmitter liberation like glycine or

adenosine receptors,156 that with antagonistic effects might possess

antidepressant actions (Table 2).157

Neurotransmitters

(Serotonin (5-HT), Dopamine NPD

[Da])

RV’s,PD’s,MaR

TX’s, LXs, LT)

COX2 inhibitor celecoxib- SCZ patients aberrant >advantage

Refractory And eicosanoids might inc DAergic Depression DAergic neurotransmission neurotransmission And ASD+SCZ

Same ASD

Severity of SCZ peripheral &brain DHA levels

SCZ

Neuropath

Ology

Altered DA levels like in SCZ Patients

amphetam

Ine induced Dec behavioral deficits,Cytokine SCZ-like Release+escalated antipsychotic Behavior and Celecoxib drug therapy (preclinical

Model)

Might change DA receptors in Seen in depre ssion-hence sig of n3PUFA ventralstriatum and status-an tenatal -studies role of PUFA’s Causehypofunction of mesolimbic in major depre ssive disorders (MDD) DA system+ anhedonia

Availability of DAT in depressed pts A-I-N-w-fluoro Propyl-carb omethoxy

With/without anhedonia -3β-(4-iodo Phenyl) tropane SPECT study

Grace AA

Diff FA’s

Du Bois et al SFA Diet

n3PUFA

diet

Eisenhofer et al

105 Antibiotic induced GM Xue et al depletion

Diaz-Heitz et al GF mice

Nishino et al 106

Crumeyrolle- 107

Arias et al

Sher et al

109 Antibiotic induced Hoban et al dysbiosis

110 n3PUFA deficiency Yuan et al alterfecal MICROBES

111 AAPassoc Cocurello et al dysbiosis

n3PUFA Robertson et al 60 &GM-tight control in

maternal env

112 n3PUFA Robertson et al gestational deprivation

n3PUFA Cardoso et al 114 deficiency

O’Mahoney et al GM preservation

Dysbiosis as well as Neuroinflammation in ASD as well as SCZ-

SCFAs

st On 1st glance the pathophysiological association among Autism

Spectrum Disorders (ASD) as well as changes in GM community

appears very astonishing. However, definitely such association is

present as well as probably depicts the biggest e.g. of the aftermath

of deranged MBC for the pathogenesis of NPDs. ASD is a dif-

ficult neurodevelopmental syndrome to fathom influencing lot of

behavioural aspects (like social interaction, motor stereotypes, self

injury) along with communication significantly. The pathophysi-

ological association among MBC as well as ASD gets corroborated SCZ Dysregulation of DA System NeuropathOlogy

Variable effects on 5-HT

neurotransmission-dec 5-HT2A

and 5-HT2C receptors binding dec n3PUFA intake-main actions on 5-HT in mamillary nucleus(inf hypoth function (receptors binding Binding and area) of rats transporter Implications in NPD Dec 5-HT2Aturnover binding in

mamillary nucleus, 5-HT2C

receptors binding in PFC & 5-HTT

Lot of tyrosine hydroxylase DA synthesis insmallintestine

GM inhibit

Dec int DA synthesis in mice peripheral

InvariantT cells

Upregulation Unequal brain mRNA in hippoca expression of mpus-dec in dorsal+ventrsa DA D1receptor (D1R) al striatum

of GF mice

Imbalance between DA and metobolitelike HVA and GF mice

DOPAC+dec DA+5-HT turnover

Same

Esp dec HVA/DA ratio-points to GF rats

dec DA turnover

Esp dec HVA/DA ratio-points to CSF In MDD dec DA turnover

Emphasis on brain

DecL-3,4-dihydroxy phenulalanine DA amt ,turn

(L-DOPA in PFC+hippocampus over,

L-DOPA+ HVA in amygdala) Metabolism

linked toGM

Atypical antipsychotics In SCZ patients

Hence variable clinical effectiveness of

AAP-

with severe side

Effects

Deeply rearrange offspring

GM-GM in mice-long-term protection Deeply rearrange offspring GM conferred

Depletion causes dec

Akkermansi a.muciniphilia

Dec SCFA generation In mice

Imp of diet lipids+Gut

Dec mesocorticolimbic DAergic Generation of catechola

and Striatonigral BDNF expression Mines+NPD pathogene Sis

Emphasis on modulation-Of ENS

DA, 5-HT-preserve GM-essential both DA, 5-HT-key players in

for MBC-communication depression&SCZ

by lots of GI disorders in ASD patients. More proof is derived

from the association among the severity of the clinical signs of

ASD as well as the exaggeration of GI symptomatology like ab-

dominal pain, bloating along with constipation as well as/or diar-

158-160 st rhea. Of the 1 posit of comorbidity among ASD as well as

GI disorders, a significant publication, where low-grade intesti-

nal inflammation (like stimulated by Clostridium tetani) was believed

to have an etiological part in ASD pathogenesis. Further lot of

studies supported the presence of lower Bacteroides to Firmutes

162,163 ratio along with escalation of Clostridium in autistic children

as well as pyrosequencing analysis aided in isolation of the bacte-

rial genus Desulfvibrio as present in greater numbers in autistic

as compared to non autistic patients.164 Usually the Proteobacteria

phyla gets over expressed in children having ASD, especially, those

possessing mental retardation (MR), as well as its spreading is

commonly correlated with IBS, gut inflammation, as well as LPS

164,167 generation. LPS stimulated endotoxaemia induces changes in

social behaviour in the offspring, even in prenatal immune chal-

lenge.163 Regarding dietary therapy intervention, probiotic admin-

istration having a pool of various strains of Lactobacillus, Bifido-

bacterium as well as Streptococcus has been illustrated to decrease

the Bacteroides to Firmutes ratio along with genus Desulfvibrio.

Further than the drastic bacterial changes in the gut of children

with ASD, other gut produced metabolites like free amino acids

(FAA) secondary to proteins as well as peptide hydrolysis, have

been correlated with ASD along with are higher in autistic sub-

jects. Of the lot of animal models of ASD, it has been seen that

administration of Bacteroides fragilis in the offspring produced

by the model of maternal immune activation (MIA) markedly re-

equilibrated, microbial ecology, decrease gut permeability as well

as ASD–like behaviours like social communication as well as anxi-

ety.169 Conversely, SCFAs might possess markedly separate actions

in ASD pathogenesis. Greater than normal amount of PPA, BA,

as well as valeric acid have been documented in autistic subjects.

These aberrant amounts might be at least partially be secondary

to the imbalance regarding particular bacterial population in ASD

like Clostridium, Bacteroides as well as Desulfvibrio that all rep-

resent critical SCFAs generators, especially PPA.168 Thus physi-

ological amounts of PPA have a part in the modulation of the

immune function, gene expression, as well as mitochondrial along

with lipid metabolism. Aberrant generation or escalation of PPA

propagates neuro inflammation via the liberation of pro inflam-

matory cytokines as well as gliosis by exaggerated proliferation of

glial progenitor cells along with impairment of neuron/glia ratio

as documented in ASD subjects. Significantly, exposure to PPA

in juvenile as well as adult rats has been formed in the form of a

model for autism for reproducing autism-like brain changes (like

neuro inflammation as well as oxidative stress) along with abnor-

mal behaviours like repetitive dystonic movements, hyperactivity

as well as deficit along with social interaction. Aberrant PPA

blood collection is also seen in the clinical problem called pro-

pionic acidemia (PA), where the fault of catabolism of branched

chain amino acid (namely the action of enzyme propionyl CoA-

Carboxylase, PCC), causes mitochondrial collection of propionyl

CoA as well as mitochondrial dysfunction. Similarly impair-

ment of mitochondrial function in seen in patients of autism along

with animals receiving icv PPA exposure.176 Though dietary factors

might have a crucial part in deciding the GM community, our in-

sight regarding probable dietary interventions of modulating gut

bacteria phenotypes is still not enough. Significantly a recent study

didn’t observe significant correlation among dietary patterns, fecal

microbiota composition as well as alterations in social deficit in

ASD children.177 However in the same study, the consumption of

particular healthy or unhealthy dietary patterns, was seen to ma-

nipulate the main incidence of selected either beneficial or harmful

bacterial taxa along with SCFAs generation. Of the various dietary

interventions/targeted nutritional methods pointed to be potential

therapies in ASD, the gluten free/casein free (GF/CF) diet, the

ketogenic diet as well as probiotic administration have been mark-

edly evaluated.178 Just like ASD children, in other NPDs like SCZ as well

as bipolar disorders (BD) a marked change in GM populations as

165,166 compared to healthy subjects occurred. Higher amounts of bac-

teria from the Lactobacillus group was detailed in a study con-

st centration on patients with 1 episode psychosis, that was seen

to be associated with severity of positive symptoms.179 Further

in same study, over representation of Lachnospiraceae as well as

Ruminococcaceae families was seen to be associated with severity

179 180 of negative symptoms. As per a later research, SCZ patients

demonstrated decreased microbial diversity of the gut flora with

an enhanced chance of Lachnospiraceae, Bacteroidaceae as well as,

Streptocococcaceae microbial species along with linear association

with symptoms severity. As probiotic administration can enhance

BDNF amounts as well as probiotics re-establish hippocampal ex-

38,181 pression following social stress, the association among SCFAs

generation as well as BDNF function might have a main key sig-

nificance for the influence of GM in SCZ pathogenesis. Potent

implication of BDNF in SCZ,182 appears from lot of function’s of

this neurotrophic factor (NF) like its significance in brain genera-

tion, neural differentiation, neurotransmitter liberation, neuronal

plasticity, cognitive alterations protection as well as survival of do-

170 183 paminergic, 5HT, as well as cholinergic neurons. Antibiotic ther-

apy of GF mice displayed changed BDNF expression in various

brain areas implicated in SCZ, that include hippocampus as well as

8,184 cingulate cortex. As seen for the part of SCFAs in depression,

butyrate can normalize BDNF expression along with depression

like behaviours in animals,147 via modes implicating BDNF-5HT

synergistic modulation as well as HDAC inhibition as well as po-

tentiation of 5HT transmission. Besides butyrate supplementa-

tion stimulating recovery of BDNF expression as well as memory

disturbance,185 its action as HDAC inhibitor gives proof for mode

for its capacity of suppressing various LPS stimulated pro inflam-

186 187 matory factors, that are known parts of SCZ pathogenesis.

Significantly stress-stimulated impairment of GM diversity as well

as alterations in brain BDNF expression are correlated with the

changes in NMDA receptor subunits, like for the reduction of

Glu N2A subunit in the hippocampus as well as cortex of germ

173 22 free (GF) mice. The decreased function of NMDA receptor is

believed to be one significant posit in SCZ pathophysiology,188 as

well as sporadic mutations of the GR1N2A gene that encodes the

Glu N2A subunit has been reported in both SCZ as well as ASD

patients.189 Prebiotic administration, as fructo-oligosaccharides

174,175 (GOS), besides facilitating hippocampal BDNF escalation, further

enhanced the expression of BDNF Glu N2A subunit, hence giv-

ing further proof that prebiotics–based Bifidobacteria prolifera-

tion promotes the expression of certain NMDA subunits.181 Fur-

ther fecal microbiome transplantation from SCZ patients to GF

mice formed aberrant hypothalamic GABA as well as glutamate

enhancement, simultaneous glutamatergic hypofunction as well as

SCZ like behaviours.180 Regarding BD, a recent comparative evalu-

ation of the stool microbiome of patients with BD, emphasized a

main reduction of the phylum Firmicutes, as well as especially of

121,190 the BA–generating Faecalibacterium. whose supplementation

has shown potential antidepressant–like actions,148 as well as whose

deficit in GM is thought to be a marker of severe inflammatory

clinical problems like CD (Table 3).134

Table 3. Association of GM changes and Diet SCFA ‘sin Depression

Ref.

Author/s GM SCFA Inflammation Enzyme Changes Neurotransmitter NPD No

Shift to>

Bacteroides

&Proteobacteria

<than healthy Sig for Jiang et al 135 subjects-Firmicutes SCFA

dec –incl prodn

Ruminococcacea

and

Lachnospiraceae

136 Butyrate- Zhang et al Class I&IIa Sig in psychiatric disorders

Valvassori 137 Inhibition of histone and Cognition in models of

et al acetylation maternal deprivation

Tsankova 138 by chromsatin Usual antidepressants like

et al str by histone SSRI,SNRI.

139 Chromatin Herre et al

Machado- 140 Valproic Acid+

Veira R et al Butyrate

Tsankova 141 Mood stabilizer+ effectiveness of imipramine like

et al neuroprotective antidepress in social defeat stress

Zhang et al

Wu et al 143 Inhibitor (VA and expression+protect midbrain

Braniste 144

et al

Yamawak 145 Rpted

et al Butyrate admn acetylation seen

Han 146

et al

147 Faecalibacterium Produces infl environment(inc Hao et al Prausnitzii.(FP) butyrate plasma IL10&prevent

Yu et al 148

Martinowich 149

et al sec to >desaturation SFA to,MUFA+dec brain

energysupply

Inhibits

imp HDAC activity

Inc BDNF Antidepressant

Na Butyrate Counterat depression-like

behavior (preclinical models &Chronic mild stress

Changes ingene

transcription Give alternate options to n by

chromsatin

str by h modification+DNA TCA,MAOinhibitors

methylation

Given modes by which

environ(diet,stress ,drugs)cause remodelling changes in gene expression

HDAC Mood stabilizer+neuroprotective inhibitor

HDAC inhitors associated with NF’s dec prevented by HDAC

inhitors-thus activate gene

transcription modelof depressio

BDNF downregulation in Esp social defeat assoc-improved

hippocampus &PFC with antidepressants

HDAC Upregulate BDNF

Sod butyrate) DAergic neurons

Butyrate crosses

BBB-oral-act as Incr histone acetylation and HDAC neurogenesis Inhibitor in

brain

Inc hippocampal histone H4 Antidepressant potential

Dec inchr Normalization of hippocampal Restraint stress-induced BDNF expression, histone H3 depressive acetylation behavior

FurtherFP admn

Reestablishes anti- Antidepressant like behavior in

CUS-induced depressive

Behavior stress ind inc CRP

+IL-6

Antidepressant therapycorrelates

BDNF expression in hippocam- Depression pathophysiolpus& PFC MAO deficiency–main ogy –thus antidepressants like

explains SSRI,SNRI.

TCA,MAOinhibitors work

Reciprocal control among BDNF Thus BDNFaids I n5-HTexpression and 5-HT transmission neuron differentiation,,dev

&function+potentiate 5-HT Aids in neural+astrocyte BDNF signaling-thro SSRI expression

Morita 150 HDAC

et al Inhibitor In rat C6 glioma cells

Sun 151 Butyrate Reversed anhedonic symptoms

et al administration in InCUS induced dec BDNF

Intlekofer 152 SCFA et al

Hoyles 153 Propionic acid et al

Szczesniak 154 Changes in GM et al

Wang 155 Same this SCFA-VA et al

Serefko 156

et al

Table 4. Correlation of Gut Microbiata (GM) with Neuropsychiatric Disease (NPDs)

Ref. Diseases-NPD/ Probiotics Role of Neurotransmitter Author/s Role of GM No IBD Effective Vagus Change with Probiotic

18 +nt Candid albicans and Brain Dis- La Fata et al ++ L.Rhamnosus Depression-DOPAC-Gut–brain streptococcusagsalactae depression,anxiety

Gut microbiome

Hasan 23 changes Influence Brain

Mohajeri et al Like altered Bacteroides function

:Fermicutes ratio

6 Chr Lactobacillus stress assoc Beneficial effect of Vagotomy Brav oet al Rhamnosus Intake Corticosterone – L.Rhamnosus (JB-1) reverses

Human gut Derived

27 Lactobacillus Barrett et al and Bifidobacteria were

cultured

28 ++ L.Rhamnosus+ All neg changes reversed with Li et al Inc Firmicutes

29 Faecal microbiota of Kelly et al Depression Microbial signatures developed anhedonia and Depressed pts

Fermicutes,

30 Bacteroides Depressionpheno Zheng et al transplantation from - Had >immobility in forced Worsened depression and actinobacteria type in GF mice

abundant in MDD pts

Decr Bifidobaand cte- Wong et al 31 rium species and incr Chronic stress

Lactobacillius causing

Valles- 32 metagenomic study Wide taxa kinds correlated Colomer et al +16S rRNA gene

Discussion And Conclusion

The summary can be seen in Table 4 is showing a correlation of

gut microbiata (GM) with neuropsychiatric disease (NPDs), Table

1 is showing GM, microglial activation, neuroinflammation and

NPD’s/brain alterations association, Table 5, is demonstrating role

of fatty acids, GM changes and NPDs with emphasis on roles of

EPA and DHA, Table 2 showing role of 5-HT-Dopamine and Promote neurosteroid BDNF gene expression Mediated cell

Differentiation+inc n5-HT-induced

Inc 5-HT- levels

InCUS-

expression

Promote neuroplasticity Supports that butyrate and

Neurogenesis,consolidating GM generating SCFA-have role as

long-term memory via BDNF- dietary derived neuroprotective

based mode and antidepressants agents

Also protects BBB and against Very sig in protecting from NPD microbial infection &inc pathogenesis permeability

Inc in valeric acid-affects NT Causes depression

liberation

This VA can influence NT release

by acting on glycine or adenosine

receptors

Synergistic effects of antagonism Cause further inc antidepressant

like caffeine & NMDA R ligands actions.

Disease Influence

Socialstress,cognition GABA+DA-products of micr

metabol module+ve assoc -QOL

Inccorticosterone,GABAAR

mRNA-Cing cortex,decr ++ L.Rhamnosus Present Antidepressant, anxiolytic GABABR-hippo,amygdale-inc

GABAA inhippo

Inccorticosterone,GABAAR Marked decr anxiety +nt mRNA-Cing

cortex,decr GABABR- Antidepressant, anxiolytic

LR,hippo,amygdale-inc blocked by vagotomy benefit GABAA inhippo

Lactobacillus Only to assess +nt with BrevisD6108 and Their ability to convert MSG HPA-axis Bifidobacterium dentium most to GABA efficient

+ve on Colonic 5FT

metabol,neg on 5FT Bifidobactlongum probiotics in rat chr mild stress metabol-pfc

Faecaltransplantation, In rats free of microbes Depression like symptoms

transfer transfer to animals anxiety like behaviors

Faecal GF mice

MDD pts worsened swimming test

Inhibited NFKB induced inflammation and inflassome

activation via IL-1β-liberation

Decr Depressed ptsbacteroides QOL decreased in

depression pts with>depression evaluation chance

n3PUFA in NPD’s and how n-3 generated eicosanoids increase

dopaminergic neurotransmission and greater DA-D1 receptors,

and help in controlling refractory depression, role of pro-resolving

mediators along with alteration in serotonin metabolism and how

gut DA and serotonin preserve MBC communication along with

enhance striato nigral BDNF generation, Table 3, demonstrating

association of GM changes and diet SCFA’s in depression, empha-

Table 5. Role of Fatty Acids, GM changes and NPDs

Ref.

Author/s n-PUFA GM Inflammaton SPM Studies/TLR NPD No

Yang et al n-3 that influences glucose Control via ALA incSFA,MUFA+proinfl SFA to,MUFA+dec brain

Serhan CN n-3 derived altered Control by SPM

Bozzatello 55 n-3 derived altered Control by SPM et al

Berger 56 n-6:n3 ratio altered et al

Kaliannan 57 IL-1β,IL-6+LPS, int Transgenic mice-could n-6:n3 ratio proteobact and dec et al permeability (signs overproduce n-6 PUFA

Same with n6 over

expression as 57. Antiinflammatory Same –how n3 Kaliannan 58 LPS levels, gut With >n-3 action of n3 et al permeability and expression overexpression

caused→

Portnoy 59 Indirect effects of

et al n3 PUFA

Robertson 60 Inc n3 PUFA et al

Pusceddu 61 n3 PUFA EFFECTS maternally separated et al

Lin et al n3 PUFA effects

Pusceddu 63 n3 PUFA effects Firmicutes: Bacteroides et al

Jory 64

Pawelczyk 65 n3 PUFA effects et al

66 n3 PUFA Rao et al deprivation

67 stmn+inhibition Yan et al n3 PUFA effects

Chassaing 68 Sense polysaccharide Bacteroides Fragilis systemic low grade on immune cells and et al A on BF

Rakoff- 69 of proinfl cytokines homeostasis by dec entry of Nahoum

et al

70 Correlate with Hug et al Altered

Possibly by alteration

in FFA metabolism SCZ cohort-have abn sec to >desaturation Then via

EPA+DHA transport and indirect eicosanoids energysupply

affect on GIT

environment

Proresolving lipid By SPM mediators

Lipoxins,resolvi SCZ, BD, ns,protectins,ma Dec n-3 PUFA in NPD depression- EPA+DHA resins

Ultra high-risk for

In young subjects depression-Predicted-mood

disorders

Inc fecal Various cascades->metabolic Inc TNF-α, Enterobacteriaceae,inc Intention to endotozaemia,fatty liver

study SCZ, ASD, +high fecal 1-methylnicotinam

Bacteroides and MDD ide,cysteine,spermidine(mark of chr infl) Actinobacteria ers of gut dysbiosis +infl

Inc bacteroides, dec Confirmed 57 results and

Transgenic mice-could how > n-3 PUFA PUFAs help in overproduce n-6 PUFA expression inc intestinal alk NPD endotoxaemia phosphatase(IAP)-

Family history of violence Dec aggression in children Same –R,double blind study +adultcaregivers

n3 PUFA environment –

Maternal prime GM in early

supplementation life-protect from HFD caused

metabolic changes

GM restored in Long-term Implicates n3 products can EPA+DHA protect in mood disorder rats supplementation

Low EPA+DHA Meta-analysis on n3 in Levels in Depression pts mood disorders depresion

Antidepressant effect still not

well understood

Dec EPA+DHAlevels Canadian children ASD

in ASD

Placebo controlled study Inc BDNF levels-inverse Inc in 1st episode SCZ –OF- correlation with depressive EPA+DHAlevels FER trial symptoms

Dec BDNF in PFC-keyarea

for SCZ+ASD

pathophysiology

Antiinfl action

via macrophage

of Mice fed NNLRP3

inflassomeactivation

+ IL-1β secretion

Thus prevent Role of TLR studied

inflammation enterocytes

Prevent activation Thus preserve intestinal

TLR recognize PAMP or NFκB mediated bact products to cytosolic

infl program inflammasome

Maintain intestestinal

TLR s essential for homeostasis

neuroinflammation gutimmune system Dysreg of TLR-

>neutoinfl&NPD

71 Microbial neurogenesis Yun et al perturbations +change in

Microbial alteration TLR4 –related infl

+dietchanges-incr signalingacc to fat

diet fat Hwang 72 SFA-palmitic and Might inc et al lauric acid-Although proinfl potential-just

n3 >MUFA but >SFA-

n-6PUF Amixed diet reciprocal action of

Raimondi 77 bile acid mediated barrier function overtake that Dietary fats et al toxic signaling affect done by n6 PUFAenriched or

Table 6. SCFA, Dysbiosis and Neuroinflammation with Neurotransmitters in ASD/SCZ/BD

Ref. Neuroinflammation and Author/s GM SCFA No Gut Problems

Buie et al 158 Altered NC ASD affects behavior-social ASD studied MBC for the pathogenesis of

Ashwood 159 Altered NC ,bloating(constipation et al

McElhanon 160 Altered NC Same et al

161 Clostridium.Tetani Low grade intestinal Bolte ER NC (CT) Inflammation due to CT correlated

Bacteroides Luna 162 :Firmicutes low NC et al &inc CT

Finegold 164 Desulfvibrio

et al Greater

Desulfvibrio Low grade Endotoxaemia Emanuele 165 liberates NC supported thus by this gram In ASD Esp severe ASD et al LPS negative anaerobe

Mostly

Plaza-Diaz 166 Proteobac

et al Teria

overrepresented

167 Proteobac Shin et al NC Inflammation&LPS Teria spread

Desulfvibrio Thus sulfur amino acid (SAA)

168 Interestingly metabolism Suh et a NC Are sulfate Defective-aberrant

reducing bact Sulfur urine excretion Astroglial and

microglal activation,

impaired

Seen in SCZ

glutamate

transmission and

NMDA subunits

Disrupt TLR

activation sensitivity, Inc LPS Activate TLRsignaling- inc mediatedinfl program

Inc risk of NPD

n3 PUFA,esp DHA Like SCZ+ASD

deactivate TLR4-TLR2-

assoc infl program ,SFA -this inhibited by DHA

can induce dimeriza-

tion of TLR4&TLR2-

>translocation of these SFA & n3 PUFA R’s to lipid raft in plasma

memb->inc downstream

signaling

Inc bile acid

secretion along with Harmful action of SFA on int

enterocyte tight n3 PUFAenriched HFD.

junction proteins

ASD/SCZ NT Gut problems and Misc

ASD-surprising that GM

connection there Represents biggest eg of altered

interaction,motor stereotypes, NPD

self injury

Lot of abdominal distention Significant correlations of GI same disorders and/or diarrhea

Meta-analysis Same

1st study to show ASD &GM

ASD IN ASD

In ASD than Pyrosequencing study of fecal M nonautistic

Mainly in MR

In ASD Also shown by 163

Assoc with IBS,Gut

In ASD Also shown by 163

generation

Explains defective immune In ASD function in ASD

Probiotic

supplemenation of

Lactobacillus,

Bifidobacterium Tomova 163 ,Streptococcusdec NC et al Bacteroides:

Firmicutes ratio

with Desulfvibrio

Prevalent

DeAngeli 169

et al

Supplementing Offspring of model of Hsiao 170 Bacteroides NC maternal immune et al Fragilis in activation(MIA)

Wang 171

et al

Imbalance with

main Clostridium.

Lopetuso 172 Bacteroides&

et al Desulfvibrio

Main producers of

SCFA esp PPA

Rossignoi

and Frye 173 PPA–modulates function,gene physiologi-

cal PPA –

modulates

Abdelli 174 Abnormal cytokines&gliosis by inc glial As documented

et al PPA-gen or inc progenitor cells& deranged in ASD

Schultz 175 like brain changes SCFA PPA in juvenile et al Neuroinflammatio%oxidative autism

MacFabe 176

DF

Role of diet –imp

Berd- role in modifying 177 SCFA Intake of sp nutrients and Social deficit seen in ASD ing and GM-healthy

Donovan &unhealthy bact

taxa

178 Targeted nutrition Potential gluten free/casein Doenas C approaches free diet,ketogenic diet

Greater

Lactobacillus

Whileover Schwarz 179 symptoms expressionin same et al corelated with negative study of

Lachnospiraceae,

Ruminaceae

Decr gut flora

withgreater Linear correlation with

Zheng 180 Lachnospiraceae, symptom severity

et al Bacteroidaceae Fecal transplantation of GM

&Streptococ- from SCZ pts

caceae

Prebiotic

Feeding

Further (FOS Savignac 181 hippocampal )&GOS et al GluN2A Bifidobacteria

prolif aids in

NMDA R subunits In ASD

Other gut derived metabolites GreaterIn NC like free AA due to protein/ Seen in ASD ASDindividuals.

peptide hydrolysis

Sig nificantly

Requilibrates GM, decr gut

Permeability and ASD-

like behavior like social

communication+anxiety

>noramts

PPA,BA,Valeric Seen in ASD

acid

in ASD

While immune physiological

expression&mitochondrial

&lipid metabolism

Neuroinflammation by proinfl

in ASD

neuron/glia ratio

Produces ASD– Exposure to Inmodel of

and adult rats stress

Causes mitochondrial Abnormal Seen in clinical problem called collection of PPA Propionic acidaemia PCoA and mitochondrial accumulation Sec to PCC enzyme Dysfunction

generation nunhealthy diet Children

Suggested as potential therapies

In ASD for ASD and Probiotics studied

deeply

Corelated with positive

st SCZ research 1 episode Psychosis

symptoms

Modulates

SCZ Inc Glutamate-Gluta- and SCZ like behavior in mice

mine- GABAcycle

Inc hippocampal BDNF, in Inc BDNF, After social stress,thus SCZ NMDAsubunits and implication of SCFA and BDNF pathogenesis d-serine function in Subunit-more proof for

Nieto 182

et al

Numaka- 183 Neurogenesis, neural function 5 HT, Pathophysiology fer fer wa et al of BDNF

Antibiotic Butyrate Bistoletti 184 Altered BDNF in treatment of GF normalizesB et al Hippocampus,cingulate mice DNF

Barichello 185 In Pneumococcal Butyrate

et al meningitis Delivery

Chriett 186 Butyrate HDAC inhibitor-mode for

et al Delivery suppression of LPS-induced

Figure 2
Figure 2. The Figure Sketches the Current Knowledge and the Potential Relationship between Mediators, Derangement of Microbial Ecosystem and Increased Liability to Neuropsychiatric Diseases (NPDs) The prevalent ingestion of dietary n-6 PUFAs (and SFAs) is linked to the drastic alterations of microbiota diversity, inflamed microenvironment, overgrowth of harmful bacterial species (e.g., Enterobactericeae), metabolic endotoxemia (increased plasma endotoxins, such as LPS) and increased intestinal permeability. Besides the upregulation of cyclooxygenases- and lipoxygenases- dependent synthesis of eicosanoids, other mechanisms may contribute to dietary n-6 PUFAs/SFAs-induced dysbiosis, such as: 1) increased expression of NF-κB signaling pathway and induction of pro-inflammatory cytokines and 2) decreased synthesis of “specialized pro-resolving mediators” (SPMs) including the resolvins (RVs) series E (RvE) and D (RvD).The overall picture of systemic

metabolic endotoxemia triggers immune dysregulation and recognition of pathogen-associated molecular patterns via toll-like receptors (TLRs) and in particular TLR4-dependent synthesis of

pro-inflammatory cytokines (e.g.,TNF-α, IL-1β, IL-6, and IL-12). In turn, reduced 5-HT synthesis, altered tryptophan metabolism and SCFAs balance contribute to dysfunctional microbiota-to-brain-

communication.The reported deficits in plasma and brain EPA/DHA levels may further contribute

and ASD.

Strong involvement of BDNF,

multiple functions in brain dev,

neural diff, NT release, neuro- SCZ

nal plasticity,cognitive changes

,protection+survival of

DAergic,

SCZ Cholinergic Of SCZ

neurons

Just like depression via Areas impli- BDNF-5 HT-synergistic control cated in Altered BDNF cortex of HDAC inhibition +potentiate SCZ

5 HT transmission

Reestablishes

BDNF expression and

promotes memory

Also acts as

proinflammatory factors

Consumption of n-6 PUFAs- and SFAs-rich Diets, Production of Pro-Inflammatory Eicosanoids to the disruption of DA and 5-HT function and, ultimately, to increased risk of depression, SCZ

sizing on role of SCFA’s, mainly butyrate in acting as HDAC inhibi-

tors, enhance H3 and H4 acetylation and aid in increasing BDNF

expression along with aid in decrease of dose of antidepressants

like SSRI’s and others and how drugs like valproic acid efficiency

improves. Table 6 showed the role of SCFA, Dysbiosis and Neu-

roinflammation with Neurotransmitters in ASD/SCZ/BD where

after boltes study showing increased Clostridium tetani correlated

in intestines of ASD children, further studies on alteration in GM

in intestine and association with ASF, SCZ ,BD and changes in

BDNF expression with roles of butyrate and even propionic acid

help along with abnormal SCFA isovaleric production harms .

Globally with the change in dietary habits with preva-

lence of western diet incidence of obesity, type 2 DM not only

have markedly increased but so have incidence of depression

along with neuropsychiatric disorders like anxiety, IBS, etc. Cur-

rently, we have atleast 4-5 patients who have got all investigations

like endoscopy, EEG, EMG and gone from pillar to post yet no

answer got with neither her gastric troubles get sorted out nor the

so called label of psychosomatic disorders for which patients are

loaded with use of drugs like clonazepam, other antianxiety drugs

and it all simply gets explained by the changes in neurochemicals

like GABA, DA serotonin as emphasized in this article so need for

changing diet habits back to our Indian type diets typically is em-

phasized or Mediterranean diet instead of the Western diet . GM

community can be drastically changed with dietary fats, in either

side via lipids of various kinds. Above we have reviewed how SFA

can cause dysbiosis as well as chances of NPD formation, as well

as selected lipids like (n-3 PUFAs )along with their metabolites can

aid in disease resilience/resolve the basic systemic as well as brain

inflammation implicated in SCZ, ASD as well as depression patho-

genesis. Whereas extensive proof corroborates the thought that

aberrant escalation of n-6: n-3 ratio is a main pathogenetic con-

nection among dietary lipids of NPDs (Figure 2), results showing

a disturbing link among n-3 PUFAs amounts, GM diversity as well

as SCFAs generation. In A population dependent study, greater

circulating amount of DHA were observed to positively associate

with greater microbiome diversity as well as greater amounts of

Lachnospiraceae family, irrespective of dietary fiber intake. Know-

ing that Lachno spiraceae family is one significant SCFAs generator,

this study points to a potential extra mode, underlying the con-

nection among n-3 PUFAs, GM health as well as lower chance

of NPDs. Similar proof on depression like behaviors produced

in mice via social isolation were seen to correlate with a switch in

GM composition, besides a reduction in SCFAs generating bacte-

ria (like Allobactum) that was sensitive to dietary DHA intake.192 In

this review lots of correlations that interrelate imbalanced intake

of selected dietary FAs towards the chances of NPDs. By utilizing

this current insight into the association of dietary lipids, disrupted

GM population as well as alterations in neuroactive substances (es-

pecially DA as well as 5HT) one might enhance our understanding

regarding NPD pathogenesis as well as design innovative thera-

peutic methods along with forming NPD related biomarkers for

getting early diagnosis as well as personalized medicine.

Informed Consent

No institutional consent needed although we are running our independent center’s all 3 authors and this review article does not

involve testing any medicine on any subjects or animals hence no

consent needed although our ethical committee does approve.

Conflicts Of Interest

The authors declare that they have no conflicts of interest.

References

  1. LynchSVPedersenO. The human intestinal microbiome in health and disease. N Engl J Med. 2016; 375: 2369-2379. doi: 10.1056/NEJMra160026610.1056/nejmra1600266 https://doi.org/10.1056/nejmra1600266
  2. FalonyGJoosensMVieira-ColomerSWangJDazziYFaustM. Population level analysis of gut microbiome variation. Science. 2016; 352: 560-564. doi: 10.1126/science.aad350310.1126/science.aad3503 https://doi.org/10.1126/science.aad3503
  3. CollinsSMSuretteMBercikP. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. 2012; 10(11): 735-742. doi: 10.1038/nrmicro287610.1038/nrmicro2876 https://doi.org/10.1038/nrmicro2876
  4. GribbleFMReimannF. Function and mechanisms of enteroendocrine cells and gut hormones in metabolism. Nat Rev Endocriniol. 2019; 15: 226-237. doi: 10.1038/s41574-019-0168-810.1038/s41574-019-0168-8 https://doi.org/10.1038/s41574-019-0168-8
  5. SkibickaKPDicksonSL. Enteroendocrine hormones-Central effects on behaviour. Curr Opin Pharmacol. 2013; 13: 977-982. doi: 10.1016/j.coph.2013.09.00410.1016/j.coph.2013.09.004 https://doi.org/10.1016/j.coph.2013.09.004
  6. BravoJAForsythePChewMVEscavarageESavignacHMDinanTG. Investigation of Lactobacillus strain regulates emotional and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A. 2011; 108: 16050-16055. doi: 10.1073/pnas.110299910810.1073/pnas.1102999108 https://doi.org/10.1073/pnas.1102999108
  7. NeufeldKAFosterJA. Effects of gut microbiota on the brain :Implications for Psychiatry. J Psychiatry Neurosci. 2009; 34: 230-231
  8. BercikPParkAJSinclairDKhoshdelALuJHuangX. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil. 2011; 23: 1132-1139. doi: 10.1111/j.1365- 2982.2011.01796.x10.1111/j.1365-2982.2011.01796.x https://doi.org/10.1111/j.1365-2982.2011.01796.x
  9. HowardRH. Vagus nerve stimulation.Curr Behav Neurosci Rep. 2014; 1: 64-73. doi: 10.1007/s40473-014-0010-510.1007/s40473-014-0010-5 https://doi.org/10.1007/s40473-014-0010-5
  10. KaurKAllahbadiaGNMandeepS. An update on etiopathogenesis and management of obesity. Obes Control Therap. 2016; 3(1): 1-17. doi: 10.15226/2374-8354/2/2/0012310.15226/2374-8354/2/2/00123 https://doi.org/10.15226/2374-8354/2/2/00123
  11. Kulvinder Kochar Kaur,Allahbadia GN,Singh Mandeep. Have Probiotics and Synbiotics passed the test of time to be implemented in management of obesity and related metabolic disorders-a comprehensive review. Adv Obes Weight Manag Control. 2019; 9(1): 21-28. doi: 10.15406/aowmc.2019.09.00269 https://doi.org/10.15406/aowmc.2019.09.00269
  12. KaurKKAllahbadiaGNSinghM. Will probiotics provide the answer for therapy of non-alcoholic fatty liver disease (NAFLD)? – A Systematic Review. Biochem Physiol. 2020; 9: 1-14
  13. KaurKAllahbadiaGNSinghM. Advances in probiotics use with the utilization of engineering technology for diseases beyond obesity, non alcoholic fatty liver disease, to treat neurodegenerative diseases, metabolic diseases like Type1 diabetes, infectious diseases and infections–A systematic review. J Endocrinol. 2020; 4(1): 1-12. doi: 10.23880/oaje-16000151-1./202010.23880/oaje-16000151-1./2020 https://doi.org/10.23880/oaje-16000151-1./2020
  14. KaurKKAllahbadiaGNSinghM. Weight loss Associated with high protein intake in obesity: Interactions of gut microbiota in protein sources influencing this positive effect. Acta Scientific Nutritional Health. 2018; 2(7): 80-89
  15. CoccurelloR. Anhedonia in depression symptamatology: Appetite dysregulation and defective brain reward processing. Behav Brain Res. 2019; 372: 112041. doi: 10.1016/j.bbr.2019.11204110.1016/j.bbr.2019.112041 https://doi.org/10.1016/j.bbr.2019.112041
  16. Dickerson E, Severance E, Yolken R.The: Microbiome, immunity and Schizophrenia abd bipolar disorder. Behav Brain Immunol. 2017; 62: 46-52. doi: 10.1016/j.bbi.2016.12.010 https://doi.org/10.1016/j.bbi.2016.12.010
  17. WhiteheadWEPalssonOJonesKR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? Gastroenterology. 2002; 122: 1140-1156. doi: 10.1053/gast.2002.3239210.1053/gast.2002.32392 https://doi.org/10.1053/gast.2002.32392
  18. La Fata G, Weber P, Mohajeri MH. Probiotics and the Gut immune system: Indirect regulation. Probiotics Antimicrob Proteins. 2018; 10: 11-21. doi: 10.1007/s12602-017-9322-6 https://doi.org/10.1007/s12602-017-9322-6
  19. Fransen F, Van Beek AA, Borghuis T, El Aidy S, Hugerholtz F, Van de Gaast de JonghC, et al. Aged gut microbiota contributes to systematical inflammaging after transfer to germ free mice. Front Immunol. 2017; 8: 1385. doi: 10.3389/fimmu.2017.01385 https://doi.org/10.3389/fimmu.2017.01385
  20. Kutak-BejdaABejdaGWaszkiewiczN. Antidepressants for irritable bowel syndrome-A systematic review. Pharmacol Rep. 2017; 69: 1366-1379. doi: 10.1016/j.pharep.2017.05.01410.1016/j.pharep.2017.05.014 https://doi.org/10.1016/j.pharep.2017.05.014
  21. RiboniFVBelzungC. Stress and psychiatric disorders: From categorical to dimensional approaches. Curr Opin Behav Sci. 2017; 14: 72-77. doi: 10.1016/j.cobeha.2016.12.01110.1016/j.cobeha.2016.12.011 https://doi.org/10.1016/j.cobeha.2016.12.011
  22. SudoNChidaYAibaYSonodaJOyamaNYuX. Postnatal microbial colonization programs the hypothalamo-pituitaryadrenal system for stress response in mice. J Physiol. 2004; 558: 263- 275. doi: 10.1113/jphysiol.2004.06338810.1113/jphysiol.2004.063388 https://doi.org/10.1113/jphysiol.2004.063388
  23. Hasan Mohajeri M, La Fata G,Steinert RE, Weber P. Relationship between the gut microbiome and brain function. Nutr Rev. 2018; 76: 481-496. doi: 10.1093/nutrit/nuy009 https://doi.org/10.1093/nutrit/nuy009
  24. OgbonnayaESClarkeGShanahanFDinanTGCryanJFO’LearyOF. Adult hippocampal neurogenesis is regulated by the Microbiome. Biol Psychiatry Neurosci. 2015; 78: e7-e9. doi: 10.1016/j. biopsych.2014.12.02310.1016/j.biopsych.2014.12.023 https://doi.org/10.1016/j.biopsych.2014.12.023
  25. DesbonnetLGarrettLClarkeGKielyBCryanJFDinanTG. Effects of the Probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience. 2010; 170(4): 1179-1188. doi: 10.1016/j.neuroscience.2010.08.00510.1016/j.neuroscience.2010.08.005 https://doi.org/10.1016/j.neuroscience.2010.08.005
  26. BharwaniAMianMFSuretteMGBienenstockJForsytheP. Oral treatment with Lactobacillus rhamnosus attenuates behavioural deficits and immune changes in chronic social stress. BMC Med. 2017; 15: 7. doi: 10.1186/s12916-016-0771-710.1186/s12916-016-0771-7 https://doi.org/10.1186/s12916-016-0771-7
  27. Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid; production by culturable bacteria from the intestine. J Appl Microbiol. 2012; 113: 411-417. doi: 10.1111/j.1365- 2672.2012.05344.x https://doi.org/10.1111/j.1365-2672.2012.05344.x
  28. LiHWangPHuangLLiPZhangD. Effects of regulating Gut Microbiota on the serotonin metabolism in the chronic unpredictable mild stress rat model. Neurogastroenterol Motil. 2019; 31: e13677. doi: 10.1111/nmo.1367710.1111/nmo.13677 https://doi.org/10.1111/nmo.13677
  29. Kelly JR, Borre Y, O’Brien C, Patterson E, El Aidy S, Deane J, et al. Transferring the blues: Depression associated Gut Microbiota induces neurobehavioral changes in the rat. J Psychiatry Res. 2016; 82: 109-118. doi: 10.1016/j.jpsychires.2016.07.019 https://doi.org/10.1016/j.jpsychires.2016.07.019
  30. ZhengPZengBZhouCLiuMFangZXuX. Gut Microbiome remodelling induces depressive like behaviours through a pathway mediated by the host’s metabolism. Mol Psychiatry. 2016; 21: 786-796. doi: 10.1038/mp.2016.4410.1038/mp.2016.44 https://doi.org/10.1038/mp.2016.44
  31. WongMLInserraALewisMDMastronardiCALeongLChooJ. Inflammasome signalling affects anxiety and depressive like behaviours and Gut Microbiome composition. Mol Psychiatry. 2016; 21: 797-805. doi: 10.1038/mp.2016.4610.1038/mp.2016.46 https://doi.org/10.1038/mp.2016.46
  32. Valles-ColomerMFaloneyGDarzyYTigchelaarEFWangJTitoRY. The neuroactive potential of the human Gut Microbiota in the quality of life and depression. Nat Microbiol. 2019; 4: 623-632. doi: 10.1038/s41564-018-0337-x10.1038/s41564-018-0337-x https://doi.org/10.1038/s41564-018-0337-x
  33. O’MahoneySMClarkeGBorreYECryanJFDinanTG. Serotonin, tryptophan metabolism and the brain-Gut Microbiome axis. Behav Brain Res. 2015; 277: 32-48. doi: 10.1016/j.bbr.2014.07.02710.1016/j.bbr.2014.07.027 https://doi.org/10.1016/j.bbr.2014.07.027
  34. MarroneMCCoccurelloR. Dietary fatty acids and microbiota–brain communication in neuropsychiatric diseases. Biomolecules. 2020; 10: 12. doi: 10.3390/biom1001001210.3390/biom10010012 https://doi.org/10.3390/biom10010012
  35. Thion MS, Low D, Silvin A, Chen J, Grisel P, Schulte–Schrepping J, et al. Microbiome influences prenatal and adult microglia in sex specific manner. Cell. 2018; 172: 500-516. doi: 10.1016/j. cell.2017.11.042 https://doi.org/10.1016/j.cell.2017.11.042
  36. HenekaMT. Microglia take centre stage in neurodegenerative disease. Nat Rev Immunol. 2019; 19: 79-80. doi: 10.1038/s41577- 018-0112-510.1038/s41577-018-0112-5 https://doi.org/10.1038/s41577-018-0112-5
  37. Bilbo SD, Block CL, BoltonJL, Hanamsagar R,Tran PK. Beyond infection-Maternal immune activation by environmental factors, microglial development, and relevance for autism spectrum disorders. Exp Neurol. 2018; 299: 241-251. doi: 10.1016/j.expneurol.2017.07.002 https://doi.org/10.1016/j.expneurol.2017.07.002
  38. BergdoltLDunaevskyA. Brain changes in a maternal immune activation model of neurodevelopmental brain disorders. Prog Neurobiol. 2019; 175: 1-19. doi: 10.1016/j.pneurobio.2018.12.00210.1016/j.pneurobio.2018.12.002 https://doi.org/10.1016/j.pneurobio.2018.12.002
  39. DinanTGCryanJF. Regulation of the stress response by the gut microbiota: Implications for psychoneuroendocrinology. Psychoneuroendocrinology. 2012; 37: 1369-1378. doi: 10.1016/j. psyneuen.2012.03.00710.1016/j.psyneuen.2012.03.007 https://doi.org/10.1016/j.psyneuen.2012.03.007
  40. SuzukiKSugiharaGOuchiYNakamuraKFutatsubashiMTakebayashiK. Microglial activation in young adults with autism spectrum disorders. JAMA Psychiatry. 2013; 70: 49-58. doi: 10.1001/jamapsychiatry.2013.27210.1001/jamapsychiatry.2013.272 https://doi.org/10.1001/jamapsychiatry.2013.272
  41. SantosSOliveiraALopezC. Systematic review of saturated fatty acids on inflammation and circulating levels of adipokines. Nutr Res. 2013; 33: 687-695. doi: 10.1016/j.nutres.2013.07.00210.1016/j.nutres.2013.07.002 https://doi.org/10.1016/j.nutres.2013.07.002
  42. ValdearcosMDouglasJDRobbleeMMDorfanMDStiflerDRBennettML. Microglial inflammatory signalling orchestrates the hypothalamic immune response to dietary excess and mediates obesity susceptibility. Cell Metab. 2017; 26(1): 185-197.e3. doi: 10.1016/j.cmet.2017.05.01510.1016/j.cmet.2017.05.015 https://doi.org/10.1016/j.cmet.2017.05.015
  43. KaaurKKAllahbadiaGNMandeepS. Current advances in pathogenesis in obesity: Impact of hypothalamic glioses. J Obes Weight Loss. 2018; 3: 008
  44. KaurKKAllahbadiaGNSinghM. Hypothalamic inflammation and glioses as aetiopathogenetic factor inhigh fat diet induced obesity and varioustherapeutic options to resolve it. Obes Res Open J. 2017; 4(2): 44-60. doi: 10.17140/OROJ-4-13210.17140/oroj-4-132 https://doi.org/10.17140/oroj-4-132
  45. KaurKKAllahbadiaGNSinghM. Synthesis and functional significance of Poly Unsaturated fatty acids (PUFA’s) in body. Acta Scientific Nutritional Health. 2018; 4: 43-50
  46. BhagvanNVHaCE. Essentials of Medical Biochemistry; Cambridge MA,USA; Academic Press: 2011
  47. LeeJMLeeHKangSBParkWJ. Fatty acid desaturases, poly unsaturated fatty acids regulation and biotechnological advances. Nutrients. 2016; 8: 23. doi: 10.3390/nu801002310.3390/nu8010023 https://doi.org/10.3390/nu8010023
  48. RussoGL. Dietary n-6 and n-3 poly unsaturated fatty acids:from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol. 2009; 77: 937-946
  49. SimopoulosAP. Evolutionary aspect of diet: The omega-6/ omega-3 ratio and the brain. Mol Neurobiol. 2011; 44: 203-215
  50. BrashAR. Arachidonic acid as a bioactive molecule. J Clin Investig. 2001; 107: 1139-1145. doi: 10.1172/JCI1321010.1172/jci13210 https://doi.org/10.1172/jci13210
  51. SpiteMClariaJSerhanCN. Resolvins,specialized pro-resolving lipid mediators, and their potential role in metabolic diseases. Cell Metab. 2014; 19: 21-36. doi: 10.1016/j.cmet.2013.10.00610.1016/j.cmet.2013.10.006 https://doi.org/10.1016/j.cmet.2013.10.006
  52. RiciottiEFitzergaldGA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011; 31: 986-1000. doi: 10.1161/AT-VBAHA.110.20744910.1161/at-vbaha.110.207449 https://doi.org/10.1161/at-vbaha.110.207449
  53. YangXSunLZhaoAHuXQingYJiangJ. Serum fatty acids patterns in patients with schizophrenia: A targeted metabolomic study. Transl Psychiatry. 2017; 7: e1176. doi: 10.1038/ tp.2017.152
  54. SerhanCN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014; 510: 92-101. doi: 10.1038/nature1347910.1038/nature13479 https://doi.org/10.1038/nature13479
  55. BozzatelloPBrignoloEDe GrandiEBellinoS. Supplementation with omega-3 fatty acids in psychiatric disorders: A review of literature data. J Clin Med. 2016; 5: 67
  56. BergerMESmesnySKimSWDaveyCGRiceCSamayiZ. Omega-6 to omega-3 poly unsaturated fatty acids ratio and subsequent mood disorders in young people with at risk mental states: A 7 year longitudinal study. Transl Psychiatry. 2017; 7: e1220
  57. KaliannanKLiXYWangBPanQChenCYHaoL. Multi-omic analysis in transgenic mice implicates omega-6/omega-3 fatty acids imbalance as a risk factor for chronic disease. Commun Biol. 2019; 2: 1-18
  58. KaliannanKWangBLiXYKimKJKangJX. A host-metabolome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxaemia. Sci Rep. 2015; 511276
  59. PortnoyJRaineALiuJHibbeinJR. Reduction of intimate partner violence resulting from supplementing children with omega-3 fatty acids: A randomized, double blind, placebo controlled, stratified parallel group trial.Aggress Behav. 2008; 44: 491-500
  60. RobertsonRCKaliannanKStrainCRRossRPStantonCKangJX. Maternal omega-3 fatty acids regulating offspring obesity through persistent modulation of gut microbiota. Metabolome. 2018; 6: 95. doi: 10.1186/s40168-018-0476-610.1186/s40168-018-0476-6 https://doi.org/10.1186/s40168-018-0476-6
  61. Pusceddu MM, El Aidy S, Crispie E, O’Sullivan O, Cotter P, Stanton C, et al. N-3 poly unsaturated fatty acids (PUFA),-reverse the impact of early–life stress on gut microbiota. PLoS One. 2015; 10: e0139721. doi: 10.1371/journal.pone.0139721 https://doi.org/10.1371/journal.pone.0139721
  62. LinPHuangSYSuKP. A meta-analytic review of polyunsaturated fatty acids composition in patients with depression. Biol Psychiatry. 2010; 68: 140-147
  63. PuscedduMMKellyPStantonCCryanJFDinanTG. N-3 polyunsaturated fatty acids through the lifespan: Implications in psychopathology. Int J Neuropsychopharmacol. 2016; 19(12): pyw078. doi: 10.1093/ijnp/pyw07810.1093/ijnp/pyw078 https://doi.org/10.1093/ijnp/pyw078
  64. JoryJ. Abnormal fatty acids in Canadian children with autism. Nutrition. 2016; 32: 474-477. doi: 10.1016/j.nut.2015.10.01910.1016/j.nut.2015.10.019 https://doi.org/10.1016/j.nut.2015.10.019
  65. PawelczykTGrancow-GrabkaMTrafalskaESzemrajJZurnerNPawelczykN. An increase in plasma brain derived neurotrophic factor levels is related to n-3 poly unsaturated fatty acid efficacy in first episode schizophrenia: Secondary outcome analysis of the OFFER randomized clinical trial. Psychopharmacology. 2019; 236: 2811-2822. doi: 10.1007/s00213-019-05258-410.1007/s00213-019-05258-4 https://doi.org/10.1007/s00213-019-05258-4
  66. RaoJSErtleyRNLeeHJDe MarJCArnoldJTRapoportSJ. N-3 poly unsaturated fatty acid deprivation in rats decreased frontal cortex BDNF via p38 MAPK-dependent mechanism. Mol Psychiatry. 2007; 12: 36-46. doi: 10.1038/sj.mp.400188810.1038/sj.mp.4001888 https://doi.org/10.1038/sj.mp.4001888
  67. YanYJiangWSpinettiTTardivelACastilloRBourquinC. Omega-3 fatty acids prevent inflammation and metabolic syndrome in mice. Immunity. 2013; 38: 1154-1163. doi: 10.1016/j. immuni.2013.05.01510.1016/j.immuni.2013.05.015 https://doi.org/10.1016/j.immuni.2013.05.015
  68. ChassaingBLeyREGewirtzAT. Intestinal epithelial cell toll like receptors 5 regulates the intestinal microbiota to prevent low grade inflammation and metabolic syndrome in mice. Gastroenterology. 2014; 147: 1363-1377.e17. doi: 10.1053/j.gastro.2014.08.03310.1053/j.gastro.2014.08.033 https://doi.org/10.1053/j.gastro.2014.08.033
  69. Rakoff-NahoumSPaglinnoJEslami-VarzanehFEdbergSMedzhitovR. Recognition of commensal microflora by toll like receptors is required for intestinal homeostasis. Cell. 2004; 118: 229-241. doi: 10.1016/j.cell.2004.07.00210.1016/j.cell.2004.07.002 https://doi.org/10.1016/j.cell.2004.07.002
  70. Hug H, Mohajeri MH, La Fata G. Toll like receptors: Regulators of the immune response in the human gut. Nutrients. 2018; 10: 203. doi: 10.3390/nu10020203 https://doi.org/10.3390/nu10020203
  71. YunSReynoldsRPMasiulisLEischAJ. Re-evaluating the link between the neuropsychiatric disorders and dysregulated adult neurogenesis. Nat Med. 2016; 22: 1239-1247. doi: 10.1038/nm.421810.1038/nm.4218 https://doi.org/10.1038/nm.4218
  72. HwangDHKimJALeeJY. Mechanisms of activation of toll like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol. 2016; 785: 24-35. doi: 10.1016/j. ejphar.2016.04.02410.1016/j.ejphar.2016.04.024 https://doi.org/10.1016/j.ejphar.2016.04.024
  73. Lopez-Morono J, Garcia-Carpintero S, Gomez-Delgado F, Jimenez-Lucena R,Vals-Delgado C, Alcala–Diaz JF, et al. Endotoxaemia is modulated by quantity and quality of dietary fats in older adults. Exp Gerontol. 2018; 109: 119-125. doi: 10.1016/j. exger.2017.11.006 https://doi.org/10.1016/j.exger.2017.11.006
  74. CamargoADelgado-ListaJGarcia-riosACruz-TenoCYubero-SerranoEMPerez-MartinezP. Expression of pro inflammatory, proatherogenic genes is reduced by mediterranean diet in elderly people. Br J Nutr. 2012; 108: 500-508. doi: 10.1017/ S0007114511005812
  75. Ba ckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004; 101: 15718-15723. doi: 10.1073/pnas.0407076101 https://doi.org/10.1073/pnas.0407076101
  76. TurnbaughPJRidauraVKFaithJJReyFEKnightRGordonJI. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009; 1(6): 6ra14. doi: 10.1126/scitranslmed.300032210.1126/scitranslmed.3000322 https://doi.org/10.1126/scitranslmed.3000322
  77. Raimondi F, Santoro P, Barone MV, Pappacoda S, Barretta ML, Nanaya kkara M, et al. Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGRF activation. Am J Physiol Gastrointest Liver Physiol. 2008; 294: G906-G913. doi: 10.1152/ajpgi.00043.2007 https://doi.org/10.1152/ajpgi.00043.2007
  78. LamYYHaCWCampbellCRMitchellAJDinudomAOscarssonJ. Increased gut permeability and microbiota changes associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One. 2012; 7(3): e34233. doi: 10.1371/journal.pone.003423310.1371/journal.pone.0034233 https://doi.org/10.1371/journal.pone.0034233
  79. Charpentier c, Chan R, Salameh E, Mbodji K, Ueno A, Coeffier M, et al. Dietary n-3 PUFAs may attenuate experimental colitis. Mediators Inflamm. 2018; 2018: 8430614. doi: 10.1155/2018/8430614 https://doi.org/10.1155/2018/8430614
  80. XiaoGTangLYuanFZhuWZhangSLiuZ. Eicosa pentaenoic acid enhances heat stress-impaired intestinal epithelial barrier function in Caco-2 Cells. PLoS One. 2013; 8: e73571
  81. SerhanCNChiangNDalliJ. The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.Seminal Immunol. 2015; 27: 200-215. doi: 10.1016/j.smim.2015.03.00410.1016/j.smim.2015.03.004 https://doi.org/10.1016/j.smim.2015.03.004
  82. ReyCDelpechJCMadoreCNadjarAGreenhalghADAmadieuC. Dietary n-3 long chain PUFAs supplementation promotes a pro-resolving oxylipin profile in the brain. Brain Behav Immun. 2019; 76: 17-27. doi: 10.1016/j.bbi.2018.07.02510.1016/j.bbi.2018.07.025 https://doi.org/10.1016/j.bbi.2018.07.025
  83. SerhanCNLevyBD. Resolvins in inflammation: Emergence of the pro-resolving super mediators of mediators. J Clin Investig. 2018; 128: 2657-2669. doi: 10.1172/JCI9794310.1172/jci97943 https://doi.org/10.1172/jci97943
  84. SerhanCNChiangNVan DykeTE. Resolving inflammation: Dual anti inflammatory and pro-resolution lipid mediators. Nat Rev Immun. 2008; 8: 349-361. doi: 10.1038/nri229410.1038/nri2294 https://doi.org/10.1038/nri2294
  85. IshidaTYoshidaMAritaMNishitaniYNishiumiS. Resolvins E1, an endogenous lipid mediator derived from eicosa pentaenoic acid, prevents dextran sodium–induced colitis. Inflamm Bowel Dis. 2010; 16: 87-95. doi: 10.1002/ibd.2102910.1002/ibd.21029 https://doi.org/10.1002/ibd.21029
  86. ChiangNBarnaevaEHuXMaruganJSouthallNFerrerM. Identification of chemotype agonists for human resolvins D1 receptor DRV1 with pro-resolving functions. Cell Chem Biol. 2019; 26: 244-254.e4. doi: 10.1016/j.chembiol.2018.10.02310.1016/j.chembiol.2018.10.023 https://doi.org/10.1016/j.chembiol.2018.10.023
  87. Deyama S, Ishikawa Y, Yoshi kawa K, Shimoda K, Ide S, Fukuda H, et al. Resolvins D1 and D2 reverse lipopolysaccharide–induced depression–like behaviors through the mTOR signaling pathway. Int J Neuropsychopharmacol. 2017; 20: 575-584. doi: 10.1093/ijnp/ pyx023 https://doi.org/10.1093/ijnp/pyx023
  88. DeyamaSShimodaKIkedaHFukudaHShutoSMinamiM. Resolvins E3 attenuates lipopolysaccharide–induced depression like behaviors in mice. J pharmacol Sci. 2018; 138: 86-88. doi: 10.1016/j.jphs.2018.09.00610.1016/j.jphs.2018.09.006 https://doi.org/10.1016/j.jphs.2018.09.006
  89. DeyamaSShimodaKSuzukiHIshikawaYIshimuraKFukudaH. Resolvins E1/E2 ameliorate lipopolysaccharide–induced depression–like behaviors via chemR23. Psychopharmacology. 2018; 235: 329-336. doi: 10.1007/s00213-017-4774-710.1007/s00213-017-4774-7 https://doi.org/10.1007/s00213-017-4774-7
  90. RobertsonRCSeira-OriachCMurphyLKMoloneyGMCryanJFDinanTG. Omega 3 poly unsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun. 2017; 116: 9644-9651
  91. ProvensiGSchmidtSDBoehmeMBastiaanssenTFSRaniBCostaA. Preventing adolescent stress–induced cognitive and microbiome changes by diet. Proc Natl Acad Sci U S A. 2019; 116: 9644-9651. doi: 10.1073/pnas.182083211610.1073/pnas.1820832116 https://doi.org/10.1073/pnas.1820832116
  92. SkosnikPDYaoJK. From membrane phospholipids to altered neurotransmitters: Is arachidonic acid a nexus in the pathophysiology of schizophrenia? Prostaglandins Leukot Essent Fat Acids. 2003; 69: 367-384. doi: 10.1016/j.plefa.2003.08.00810.1016/j.plefa.2003.08.008 https://doi.org/10.1016/j.plefa.2003.08.008
  93. ZhengWCaiDBYangXHUngvariGSNgCHMullerN. Adjunctive celecoxib for schizophrenia? A meta-analysis of randomized, double blind, placebo controlled trials. J Psychiatry Res. 2017; 92: 139-146. doi: 10.1016/j.jpsychires.2017.04.00410.1016/j.jpsychires.2017.04.004 https://doi.org/10.1016/j.jpsychires.2017.04.004
  94. GrossoGGalvanoFMarventanoSMalaguarneraMBucoloCDragoF. Omega 3 fatty acids and depression:Scientific evidence and biological mechanisms. Oxid Med Cell Longev. 2014; 2014: 313570. doi: 10.1155/2014/31357010.1155/2014/313570 https://doi.org/10.1155/2014/313570
  95. TamijiJCrawfordDA. The neurobiology of lipid metabolism in autism spectrum disorders. Neurosignals. 2010; 18: 98-112. doi: 10.1159/00032318910.1159/000323189 https://doi.org/10.1159/000323189
  96. HoenWPLijmerJGDuranMWandersRJAVan BeverenNJMDe HaanL. Red blood cell Omega 3 polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis. Psychiatry Res. 2013; 207: 1-12. doi: 10.1016/j.psychres.2012.09.04110.1016/j.psychres.2012.09.041 https://doi.org/10.1016/j.psychres.2012.09.041
  97. Montenos-Rueda L,Canete-CrespilloJ, Palma-Sevillano C, Gine serven E. Erythrocyte membrane polyunsaturated fatty (pufa) levels in a sample of patients with schizophrenia and relation with clinical and progression values. Actas Esp Psiquiatr. 2015; 43: 170- 176
  98. ChalonS. Omega 3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids. 2006; 75: 259-269. doi: 10.1016/j.plefa.2006.07.00510.1016/j.plefa.2006.07.005 https://doi.org/10.1016/j.plefa.2006.07.005
  99. El Sayed El Sisi A, Sokkar SS, El Sayed El Sayed M, Sayed Ramadan E, Osman EY. Celecoxib and Omega 3 fatty acids alone and in combination with risperidone affect the behaviour and brain biochemistry in amphetamine induced model of schizophrenia. Biomed Pharmacother. 2016; 82: 425-431. doi: 10.1016/j. biopha.2016.05.024 https://doi.org/10.1016/j.biopha.2016.05.024
  100. SubletteMEGalfalvyHCHibbelnJRKeilpJGMaloneKPOquendoMA. Poly unsaturated fatty acid associations with dopaminergic indices in major depressive disorders. Int J Neuropsychopharmacol. 2014; 17: 383-391. doi: 10.1017/S146114571300139910.1017/s1461145713001399 https://doi.org/10.1017/s1461145713001399
  101. CamardeseGDe RisioLDe NicolaMPucciLCocciolilloPBrioP. Changes of dopamine transporter availability in depressed patients with and without anhedonia: AI-Nω-fluoropropylcarbomethoxy-3β-(4iodophenyl) tropane SPECT study. Neuropsychobiology. 2014; 70: 235-243. doi: 10.1159/00036811710.1159/000368117 https://doi.org/10.1159/000368117
  102. GraceAA. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat Rev Neurosci. 2016; 17: 524. doi: 10.1038/nrn.2016.5710.1038/nrn.2016.57 https://doi.org/10.1038/nrn.2016.57
  103. Du Bois TM, Deng C, Bell W, Huang X. Fatty Acids differentially affect serotonin receptor and transporter binding in the rat brain. Neuroscience. 2006; 139: 1397-1403. doi: 10.1016/j.neuroscience.2006.02.068 https://doi.org/10.1016/j.neuroscience.2006.02.068
  104. EisenhoferGAnemonAFribergPHooperDFrandriksLLonrothH. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997; 82: 3864- 3871. doi: 10.1210/jcem.82.11.433910.1210/jcem.82.11.4339 https://doi.org/10.1210/jcem.82.11.4339
  105. XueRZhangHPanJDuZZhouWZhangZ. Peripheral dopamine controlled by gut microbes inhibits invariant natural killer cell-mediated hepatitis. Front Immunol. 2018; 9: 2398. doi: 10.3389/fimmu.2018.0239810.3389/fimmu.2018.02398 https://doi.org/10.3389/fimmu.2018.02398
  106. NishinoRMikamiKTakahashiHTamonnagaSFuruseMHiramotoT. Commensal microbiota modulates murine behaviours in a strictly contamination free environment confirmed by culture based methods. Neurogasteroenterol Motil. 2013; 25: 521- 528. doi: 10.1111/nmo.1211010.1111/nmo.12110 https://doi.org/10.1111/nmo.12110
  107. Crumeyrolle-AriasMJaglinMBruneauAVancasselSCardonaADaugeV. Absence of the gut microbiota enhances anxiety like behaviour and neuroendocrine responses to acute stress in rats. Psychoneuroendocrinology. 2014; 42: 207-217. doi: 10.1016/j.psyneuen.2014.01.01410.1016/j.psyneuen.2014.01.014 https://doi.org/10.1016/j.psyneuen.2014.01.014
  108. SherLOquendoMALiSBurkeAKGrunebaumMFZalsmanG. Higher cerebrospinal fluid homovanillic acid levels in depressed patients with comorbid post traumatic stress disorder. Eur Psychopharmacol. 2005; 15: 203-209. doi: 10.1016/j.euroneuro.2004.09.00910.1016/j.euroneuro.2004.09.009 https://doi.org/10.1016/j.euroneuro.2004.09.009
  109. Hoban AE, Moloney RD, Golubeva AV, McVey Neufeld KA, O’Sullivan O, Patterson E, et al. Behavioral and neurochemical consequences of chronic gut microbiota depletion during adulthood in rat. Neuroscience. 2016; 339: 463-477. doi: 10.1016/j.neuroscience.2016.10.003 https://doi.org/10.1016/j.neuroscience.2016.10.003
  110. YuanXZhangPWangYLiuYLiXKumarBU. Changes in metabolism and microbiota after 24 week risperidone treatment in drug naive, normal weight patients with first episode of schizophrenia. Schizophr Res. 2018; 201: 299-306. doi: 10.1016/j. schres.2018.05.01710.1016/j.schres.2018.05.017 https://doi.org/10.1016/j.schres.2018.05.017
  111. CocurelloRMolesA. Potential mechanisms of atypical antipsychotic induced-metabolic derangement: Clues for understanding obesity and novel drug design. Pharmacol Ther. 2010; 127: 210- 251. doi: 10.1016/j.pharmthera.2010.04.00810.1016/j.pharmthera.2010.04.008 https://doi.org/10.1016/j.pharmthera.2010.04.008
  112. RobertsonRCSeira-OriachCMurphyLKMoloneyGMCryanJFDinanTG. Deficiency of essential dietary n-3 PUFA disrupts the caecal microbiome and metabolome in mice. Br J Nutr. 2017; 118: 959-970. doi: 10.1017/S000711451700299910.1017/s0007114517002999 https://doi.org/10.1017/s0007114517002999
  113. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, et al. Normal gut microbiota modulate brain development and behaviour. Proc Natl Acad Sci U S A. 2011; 108: 3047- 3052. doi: 10.1073/pnas.1010529108 https://doi.org/10.1073/pnas.1010529108
  114. ZhaoLZhangFDingXWuGLamYYWangX. Gut bacteria selectively promoted by dietary fibres alleviate type 2 diabetes. Science. 2018; 359: 1151-1156. doi: 10.1126/science.aao577410.1126/science.aao5774 https://doi.org/10.1126/science.aao5774
  115. Cardoso HD, Dos Santos EFJr, De Santana DF, Goncalves-Pimentel C, Angelim MK, Isaac AR, et al. Omega 3 Deficiency and neurodegeneration in the substantia nigra: Involvement of increased nitric oxide production and reduced BDNF expression. Biochim Biophys Acta Gen Subj. 2014; 1840: 1902-1912. doi: 10.1016/j.bbagen.2013.12.023 https://doi.org/10.1016/j.bbagen.2013.12.023
  116. Den Besten G, Van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013; 54: 2325-2340. doi: 10.1194/jlr.R036012 https://doi.org/10.1194/jlr.r036012
  117. HoruchiYKimuraRKatoNFuijiTSekiMEndoT. Evolutional study on acetyl choline expression. Life Sci. 2003; 72: 1745-1756. doi: 10.1016/s0024-3205(02)02478-510.1016/s0024-3205(02)02478-5 https://doi.org/10.1016/s0024-3205(02)02478-5
  118. TerryNMargolisKG. Serotonergic mechanisms regulating the GI tract: Experimental evidence and therapeutic relevance. Handb Exp Pharmacol. 2017; 239: 319-342. doi: 10.1007/164_2016_10310.1007/164_2016_103 https://doi.org/10.1007/164_2016_103
  119. David LA Maurice CF, Carmody RN, Gootenberg DB, Burton JE, Wolfe BE, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014; 505: 559-563. doi: 10.1038/ nature12820
  120. UrangaJALopez-MirandaVLomboEAbaloR. Food, nutrients and nutraceuticals affecting the course of inflammatory bowel diseases. Pharmacol Rep. 2016; 68: 816-826
  121. HoldGL. Western lifestyle: A master manipulator of the intestinal microbiota? Gut. 2014; 63: 5-6. doi: 10.1136/ gutjnl-2013-304969
  122. Martinez–Medina M, Denizot J, Dreux N, Robin F, Billard E, Bonnet R, et al. Western diet induces dysbiosis with increased e.coli in CEABAC 10mice, alters host barrier function favouring AIEC colonisation. Gut. 2014; 63: 116-124. doi: 10.1136/ gutjnl-2012-304119
  123. TangMHWWangZLevisonBSKorthRABrittEBFuX. Intestinal microbial metabolism in phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013; 368: 1575-1584. doi: 10.1056/NEJMoa110940010.1056/nejmoa1109400 https://doi.org/10.1056/nejmoa1109400
  124. PandyalaSWalkerJMHoltPR. A high fat diet is associated with endotoxaemia that originates from the gut. Gasteroenterology. 2012; 142: 1100-1101. e2. doi: 10.1053/j.gastro.2012.01.03410.1053/j.gastro.2012.01.034 https://doi.org/10.1053/j.gastro.2012.01.034
  125. SokolHPigneurBWatterlotLLakhdariOBermudez-HumaranLGGrandouxJJ. Faecalibacterium prausnitzii is an-anti inflammatory commensal bacterium identified by gut microbiota analysis of Crohns disease patients. Proc Natl Acad Sci U S A. 2008; 105: 16731-1736. doi: 10.1073/pnas.080481210510.1073/pnas.0804812105 https://doi.org/10.1073/pnas.0804812105
  126. Agus A, Denizot J, Thevenot J, Martinez–Medina M, Massier S, Sauvanet P, et al. Western diet induces a shift in microbiota composition enhancing susceptibility to adherent invasive E.Coli infection and Intestinal inflammation. Sci Rep. 2016; 6: 19032
  127. TurnbaughPJBackheadFFultonLGordonJI. Diet induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe. 2008; 3: 213-223. doi: 10.1016/j.chom.2008.02.01510.1016/j.chom.2008.02.015 https://doi.org/10.1016/j.chom.2008.02.015
  128. Parada-Venegas D, De la Fuente MK, Landskron G, Gonzalez MJ, Quera R, Dijkstra G, et al. Short chain fatty acids (SCFA)- Mediated gut epithelial and immune regulation and its reversal for inflammatory bowel diseases. Front Immunol. 2019; 10: 277. doi: 10.3389/fimmu.2019.00277 https://doi.org/10.3389/fimmu.2019.00277
  129. SmithPMHowittMRPanikovNMichaudMGalliniCABohloolyYM. The microbial metabolites, Short chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013; 341: 569-573. doi: 10.1126/science.124116510.1126/science.1241165 https://doi.org/10.1126/science.1241165
  130. SinghNGuravASivaprakasamSBradyEPadiaRShiH. Activation of Gpr 109a, receptor for niacin and the commensal,metabolite butyrate suppresses colonic inflammation and carcinogenesis. Immunity. 2014; 40: 128-139. doi: 10.1016/j.immuni.2013.12.007 Sci Rep. 2018; 8: 7410.1016/j.immuni.2013.12.007 https://doi.org/10.1016/j.immuni.2013.12.007
  131. LaurraufiePMartin-GallausiauxCLapaqueNDoreJGribbleFMGribbleFMReimannF. SCFAs strongly stimulate PYY production in human enteroendocrine cells. Nature. 2018; 8(1). doi: 10.1038/s41598-017-18259-010.1038/s41598-017-18259-0 https://doi.org/10.1038/s41598-017-18259-0
  132. LiuJSunJWangFYuXLingZLiH. Neuroprotective effects of Clostridium butyricum against Vascular dementia in mice via metabolic butyrate. Biomed Res Int. 2015; 2015: 412946. doi: 10.1155/2015/41294610.1155/2015/412946 https://doi.org/10.1155/2015/412946
  133. ByrneCSChambersESAlhabeebHChhinaNMorrisonDJPrestonT. Increased colonic propionate reduces anticipatory reward responses in the human striatum to high energy foods. Am J Clin Nutr. 2016; 104: 5-14. doi: 10.3945/ajcn.115.12670610.3945/ajcn.115.126706 https://doi.org/10.3945/ajcn.115.126706
  134. BenusRFJVan der WerfTSWellingGWJuddPATaylorMA. Association between Faecalibacterium prasnitzii and dietary fibres in colonic fermentation in healthy human subjects. Br J Nutr. 2010; 104: 693-700. doi: 10.1017/S000711451000103010.1017/s0007114510001030 https://doi.org/10.1017/s0007114510001030
  135. LouisPFlintHJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lette. 2009; 294: 1-8. doi: 10.1111/j.1574- 6968.2009.01514.x10.1111/j.1574-6968.2009.01514.x https://doi.org/10.1111/j.1574-6968.2009.01514.x
  136. JiangHLingZZhangYMaoHMaZYinY. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immunol. 2015; 48: 186-194. doi: 10.1016/j. bbi.2015.03.01610.1016/j.bbi.2015.03.016 https://doi.org/10.1016/j.bbi.2015.03.016
  137. ZhangJZhongQ. Histone deacetylase inhibitors and cell death. Cell Mol Life Sci. 2014; 71: 3885-3901. doi: 10.1007/s00018- 014-1656-610.1007/s00018-014-1656-6 https://doi.org/10.1007/s00018-014-1656-6
  138. ValvassoriSVarelaRArentCDal-PontGBobsinTBudniJ. Sodium butyrate function as an antidepressant and improves cognition with enhanced neurotrophic expression in m odels of maternal deprivation and chron ic mild stress. Curr Neurovasc Res. 2014; 11: 3885-3901. doi: 10.2174/156720261166614082916215810.2174/1567202611666140829162158 https://doi.org/10.2174/1567202611666140829162158
  139. TsankovaNRenthalWKumarANestlerEJ. Epigenetic regulation in psychiatric disorders. Nat Rev Neuro Sci. 2007; 8: 355-367. doi: 10.1038/nrn213210.1038/nrn2132 https://doi.org/10.1038/nrn2132
  140. HerreMKorbE. The chromatin landscape of neuronal plasticity. Curr Opin Neurobiol. 2019; 59: 79-86. doi: 10.1016/j. conb.2019.04.00610.1016/j.conb.2019.04.006 https://doi.org/10.1016/j.conb.2019.04.006
  141. Machado-VeiraRIbrahimLZarateC. Histone deacetylases and mood disorders: Epigenetic programming in gene-environmental interactions. CNS Neurosci Ther. 2011; 17: 699-704. doi: 10.1111/j.1755-5949.2010.00203.x10.1111/j.1755-5949.2010.00203.x https://doi.org/10.1111/j.1755-5949.2010.00203.x
  142. TsankovaNMBertonORenthalWKumarANeveRLNestlerEJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci. 2006; 9: 519-525. doi: 10.1038/nn165910.1038/nn1659 https://doi.org/10.1038/nn1659
  143. ZhangJYaoWDongCYangCRenQMaH. Comparison of ketamine, 7,8-dihydroxy flavones, and ANA 12 antidepressant effects in the social defeat stress model of depressio. Psychopharmacology (Berl). 2015; 232: 4325-335. doi: 10.1007/s00213- 015-4062-310.1007/s00213-015-4062-3 https://doi.org/10.1007/s00213-015-4062-3
  144. WuXChenPSDallasSWilsonBBlockMIWangCC. Histone deacetylase inhibitors upregulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. Int J Neuropsychopharmacol. 2008; 11: 1123-1134. doi: 10.1017/ S1461145708009024
  145. BranisteVAl-AsmakhMKowalCAnuarFAbbaspourATothM. The gut microbiota influences blood brain barrier permeability in mice. Sci Transl Med. 2014; 6: 263ra158. doi: 10.1126/scitranslmed.300975910.1126/scitranslmed.3009759 https://doi.org/10.1126/scitranslmed.3009759
  146. YamawakiYFuchikamiMMorinobuSSegawaMMatsumotoTYamawakiS. Antidepressant-like effect of Sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry. 2012; 13: 458-467. doi: 10.3109/15622975.2011.58566310.3109/15622975.2011.585663 https://doi.org/10.3109/15622975.2011.585663
  147. HanASungYBChungSYKwonMS. Possible additional Antidepressant-like mechanism of Sodium butyrate: Targeting the hippocampus. Neuropharmacology. 2014; 81: 292-302. doi: 10.1016/j. neuropharm.2014.02.01710.1016/j.neuropharm.2014.02.017 https://doi.org/10.1016/j.neuropharm.2014.02.017
  148. HaoZWangWGuoRLiuH. Faecalibacterium prasnitzii (ATCC27766) has preventive and therapeutic effects on chronic unpredictable stress-induced depression–like and anxiety like behaviour in rats. Psychoneuroendocrinology. 2019; 104: 132-142. doi: 10.1016/j.psyneuen.2019.02.02510.1016/j.psyneuen.2019.02.025 https://doi.org/10.1016/j.psyneuen.2019.02.025
  149. YuZChenZY. The role of BDNF in depression on the basis of its location in neural circuitry. Acta Pharmacol Sin. 2011; 32: 3-11. doi: 10.1038/aps.2010.18410.1038/aps.2010.184 https://doi.org/10.1038/aps.2010.184
  150. MartinowichKLuB. Interaction between BDNF and serotonin: Role in mood disorders. Neuropsychopharmacology. 2008; 33: 73-83. doi: 10.1038/sj.npp.130157110.1038/sj.npp.1301571 https://doi.org/10.1038/sj.npp.1301571